Organic microspheres for use in personalized medicine and drug development

JP2023553838A5Inactive Publication Date: 2024-11-29XILIS INC +4
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2023532557
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2020-11-25
Filing Date
2021-11-23
Publication Date
2024-11-29
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Conventional 2D cell cultures do not accurately represent individual patient responses, and existing 3D models like organoids are cumbersome to create, requiring large cell samples and taking weeks to mature, with significant variability in size and cell number.

Method used

A system and method for generating organic microspheres using a microfluidic device that forms microspheres from biological samples, allowing for rapid production of uniform microspheres with controlled properties, suitable for drug screening and personalized medicine applications.

Benefits of technology

Enables rapid production of uniform organic microspheres from small biological samples, facilitating high-throughput drug screening and personalized medicine by providing a controlled environment for cell growth and drug response analysis.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

Disclosed herein are systems, devices, and methods for forming organic microspheres. In some variations, the system may include an organic microsphere generator configured to form a set of organic microspheres from a mixture of a biological sample and a fluid. A controller may be coupled to an imaging device. The controller may be configured to receive imaging data corresponding to one or more of the mixture or the set of organic microspheres, and to estimate one or more properties of the set of organic microspheres based at least on the imaging data.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] Cross - reference to related applications

[0001] This application claims priority to U.S. Provisional Patent Application No. 63 / 118,528, filed on November 25, 2020, the content of which is hereby incorporated by reference in its entirety.

[0002] Technical Field

[0002] This disclosure generally relates to the development of personalized pharmaceuticals and drugs, and particularly to the generation of organic micro - organospheres and their use in the development of personalized pharmaceuticals and drugs.

Background Art

[0003] Background

[0003] Model cells and tissue systems are useful for biological research and medical research. The most common practice is to derive immortalized cell lines from tissues and culture them in two - dimensional (2D) coordinates (e.g., Petri dishes or well plates). Although useful for basic research, 2D cell lines do not correlate well with the individual patient responses to treatment. Three - dimensional (3D) cell culture models are particularly useful in developmental biology, disease pathology, regenerative medicine, drug toxicity and efficacy testing, and personalized pharmaceuticals. For example, spheroids and organoids are 3D cell aggregates that have been studied. However, both organoids and spheroids have limitations that reduce their efficacy.

Summary of the Invention

Problems to be Solved by the Invention

[0004]

[0004] Organoids are in vitro derived cell aggregates containing a population of stem cells capable of differentiating into cells of major cell lineages. Organoids typically have a diameter greater than 1 mm. Organoids typically grow and proliferate more slowly than 2D cell cultures. To generate organoids from clinical samples, the input sample must contain hundreds of thousands of living cells, and therefore, organoids often cannot be created from low-volume samples such as biopsies. Organoids, if possible, must be cultured for several weeks before they are ready for experimental use. Organoids also vary considerably in size, shape, and cell count. Therefore, additional 3D tissue modeling systems, devices, and methods may be desirable. [Means for solving the problem]

[0005] overview

[0005] The disclosure generally relates to systems and methods for forming organic microspheres. In one embodiment, the disclosure provides a system including an organic microsphere generator, which includes a microfluidic device and is configured to form a set of organic microspheres from a mixture of a biological sample and a fluid. A controller may be coupled to an imaging device. The controller may be configured to receive imaging data corresponding to one or more of the mixture or a set of organic microspheres and to estimate the properties of one or more of the set of organic microspheres based on at least the imaging data.

[0006]

[0006] In some variations, the imaging device may be configured to generate imaging data corresponding to one or more of a mixture or a set of organic microspheres. In some variations, a cell culture vessel may be coupled to the imaging device and configured to culture a set of organic microspheres in multiple wells. The controller may be configured to estimate the number of organic microspheres in the multiple wells based on at least the imaging data. In some variations, a cell culture vessel may be coupled to the imaging device and configured to culture a set of organic microspheres in multiple wells. The controller may be configured to estimate the number of organic microspheres in the multiple wells based on at least the imaging data.

[0007]

[0007] In some variations, one or more sensors may be coupled to the microfluidic device and configured to generate sensor data corresponding to a mixture or a set of organic microspheres. The controller may be configured to receive sensor data from one or more sensors and to estimate the properties of one or more of a set of organic microspheres based on at least the sensor data. In some variations, one or more pumps may be coupled to the microfluidic device and configured to control the fluid flow to the microfluidic device. A temperature controller may be coupled to the microfluidic device, a sample source, or a fluid source and configured to control the temperature of the sample source, a fluid source, a mixture, or a set of organic microspheres. The controller may be configured to change one or more pumps or temperatures based on at least the imaging data and sensor data.

[0008]

[0008] In some variations, a polymerizer may be fluidly coupled to a microfluidic device and configured to polymerize the mixture to form a set of organic microspheres. In some variations, a demulsifier may be fluidly coupled to a microfluidic device and configured to demulsify the mixture to form a set of organic microspheres. In some variations, the demulsifier may include a flow separator configured to separate the set of organic microspheres. In some variations, the flow separator may extend along the length of the demulsifier. In some variations, a stirrer may be configured to stir the organic microspheres in a fluid of a predetermined concentration.

[0009]

[0009] In some variations, one or more properties of a set of organic microspheres may include one or more of the diameter of the organic microspheres, the total number of cells, or the number of living cells. In some variations, the controller may be configured to estimate one or more properties of the mixture based on at least the imaging data. In some variations, one or more properties of the mixture may include the total number of cells and the number of living cells.

[0010]

[0010] In some variations, the imaging data may correspond to a biological sample, and the controller may be configured to estimate one or more properties of the biological sample based on at least the imaging data. In some variations, one or more properties of the biological sample may include the total number of cells and the number of living cells. In some variations, a set of organic microspheres may have a diameter of about 200 μm to about 400 μm.

[0011]

[0011] In some variations, the organic microsphere generator may be configured to form a pair of organic microspheres from a biological sample containing up to about 1 mL in volume. In some variations, the organic microsphere generator may be configured to form a pair of organic microspheres from a biological sample containing fewer than about 10,000 cells. In some variations, the biological sample may contain about 3,500 to about 7,500 cells.

[0012]

[0012] In some variations, the organic microsphere generator may be configured to form a set of organic microspheres from a biological sample having a volume of about 5 μL to about 5 mL. In some variations, the biological sample may have a volume of about 5 μL, about 10 μL, about 20 μL, about 35.3 μL, about 50 μL, about 100 μL, about 250 μL, about 500 μL, about 1 mL, about 1.5 mL, about 2 mL, about 2.5 mL, about 3 mL, about 3.5 mL, about 4 mL, about 4.5 mL, or about 5 mL.

[0013]

[0013] In some variations, a set of organic microspheres may contain a set of noncellular objects. In some variations, a set of noncellular objects may contain one or more inert particles. In some variations, a set of noncellular objects may contain about 1 to about 5,000 inert particles.

[0014]

[0014] Another aspect of the present disclosure relates to a system comprising an organic microsphere generator configured to form a set of organic microspheres from a mixture of a biological sample and a fluid, and a controller configured to receive imaging data corresponding to a set of organic microspheres and to identify a set of organic microspheres having a diameter of about 50 to about 500 μm, based at least on the imaging data.

[0015]

[0015] In some variations, the imaging device may be configured to generate imaging data corresponding to a set of organic microspheres. In some variations, the biological sample corresponds to a patient's biopsy.

[0016]

[0016] Another aspect of the present disclosure is a method for creating an organic microspherical composition in a system, comprising: providing a biological sample comprising dissociated cells and a nonpolymerizable substrate; forming a mixture from the biological sample in an immiscible solution; and polymerizing the mixture to form a set of organic microsphericals.

[0017]

[0017] In some modifications, biological samples can be dissociated to obtain dissociated cells. In some modifications, the substrate can be susceptible to temperature, and polymerization occurs when the temperature of the mixture rises. In some modifications, a set of organic microspheres may have an average diameter of about 50 μm to about 500 μm, and a coefficient of dispersion (CV) of less than about 30%, less than about 20%, or less than about 10%.

[0018]

[0018] In some variations, the organic spheres can be sorted by size to form a set of organic microspheres having an average diameter of about 50 μm to about 500 μm and a coefficient of dispersion (CV) of less than about 30%, less than about 20%, or less than about 10%, or the flow rate of one or more organic microspheres can be controlled to form a set of organic microspheres having an average diameter of about 50 μm to about 500 μm and a coefficient of dispersion (CV) of less than about 30%, less than about 20%, or less than about 10%.

[0019]

[0019] In some variations, the assay may be performed on organic microspheres to identify the treatment response. In some variations, the assay may be a cell viability assay or a cell staining assay. In some variations, the assay may be performed within 14 days or less of the time the biological sample is obtained from the patient. In some variations, the organic microspheres may contain about 1 to about 1,000 dissociated primary cells dispersed in a substrate. In some variations, the biological sample may correspond to a patient biopsy.

[0020]

[0020] Another aspect of the present disclosure relates to an organic microspherical composition comprising a substrate and a plurality of organic microspherical bodies comprising at least one organoid. The plurality of organic microspherical bodies may have parameters including a predetermined number of cells per droplet, a predetermined number of droplets per composition, and / or a predetermined droplet size. Each of the parameters may independently have a coefficient of dispersion (CV) of less than about 30%, less than about 20%, or less than about 10%.

[0021]

[0021] In some variations, the average diameter of each organic microsphere in the composition can be from about 50 μm to about 500 μm. In some variations, the average diameter of each organic microsphere in the composition can have a coefficient of variation (CV) of less than about 30%, less than about 20%, or less than about 10%.

[0022]

[0022] In some variations, each organic microsphere can include a substrate and only one organoid. In some variations, each organic microsphere can further include inert particles. In some variations, the inert particles can be magnetic particles, magnetizable particles, fluorescent particles, or combinations thereof. In some variations, each organic microsphere can include from about 1 to about 5,000 inert particles.

[0023]

[0023] In some variations, the plurality of organic microspheres can include tissue from a patient biopsy. In some variations, the tissue can include non-cultured cells. In some variations, the organic microspheres can include from about 1 to about 1,000 dissociated primary cells dispersed within the substrate.

[0024]

[0024] Another aspect of the present disclosure relates to a method of immobilizing organic microspheres in a well or culture plate, the method comprising providing a plurality of organic microspheres, each organic microsphere including a substrate, at least one organoid, and magnetic or magnetizable particles; and applying a magnetic field to the well or culture plate, thereby immobilizing the organic microspheres on the surface of the well or culture plate.

[0025]

[0025] In some variations, the well or culture plate has a bottom, and the organic microspheres are immobilized on the bottom of the well or culture plate.

[0026]

[0026] Another aspect of the present disclosure relates to a method for immobilizing organic microspheroids in a well or culture plate having a bottom, the method comprising providing a plurality of organic microspheroids, each organic microspheroid comprising a substrate and at least one organoid, functionalizing the bottom with an antibody bound to the substrate, and contacting the organic microspheroids with the antibody, thereby immobilizing the organic microspheroids to the bottom.

[0027]

[0027] In some variations, the antibody may be immobilized at the bottom by incubation. In some variations, the bottom may be coated with protein A and / or protein G before functionalization.

[0028]

[0028] Another aspect of the present disclosure relates to a method for identifying a patient's response to a treatment, the method comprising performing an assay on organic microspheres, the organic microspheres being produced by mixing a biological sample containing cells dissociated from a patient in an immiscible solution with a nonpolymerizable substrate to produce a mixture, and polymerizing the mixture to form a set of organic microspheres.

[0029]

[0029] In some variations, the assay may be a cell viability assay or a cell staining assay. In some variations, the assay may be performed within 14 days or less of the time the biological sample is obtained from the patient. In some variations, the organic microspheres may contain about 1 to about 1,000 dissociated primary cells dispersed within the substrate.

[0030]

[0030] Further modifications, features, and advantages of the present invention will become apparent from the following detailed description and through the implementation of the present invention. [Brief explanation of the drawing]

[0031] Brief explanation of the drawing [Figure 1]

[0031] This is a block diagram of an exemplary modified organic microspherical body forming system. [Figure 2A]

[0032] This is a schematic diagram of an exemplary variation of an organic microspherical body formation system. [Figure 2B]

[0032] This is a schematic diagram of an exemplary variation of a demulsifier. [Figure 2C]

[0032] This is a schematic diagram of another exemplary variation of the organic microspherical body forming system. [Figure 2D]

[0032] This is a schematic diagram of another exemplary variation of the organic microspherical body forming system. [Figure 3A]

[0033] This is a schematic diagram of an exemplary variation of an organic microspherical body formation system. [Figure 3B]

[0033] This is a schematic diagram of another exemplary variation of the organic microspherical body forming system. [Figure 4A]

[0034] This is a plan view of one example of a modified organic microspherical body formation system. [Figure 4B]

[0034] Figure 4A is a perspective view of the organic microspherical body formation system in a closed configuration. [Figure 4C]

[0034] Figure 4A is a perspective view of the organic microspherical body formation system shown in the open configuration. [Figure 5]

[0035] This is a cross-sectional view of an exemplary and modified organic microspherical body generator. [Figure 6A]

[0036] This is a schematic diagram of one example variation of a demulsifier. [Figure 6B]

[0036] This is an exemplary modified cross-sectional view of a demulsifier. [Figure 7]

[0037] This is an image of one example of a modified organic microspherical body formation system. [Figure 8]

[0038] This is a flowchart illustrating one variation of an example of a method for forming organic microspherical bodies. [Figure 9]

[0039] This is a flowchart of another exemplary variation of the method for forming organic microspheres. [Figure 10]

[0040] This is an illustrative block diagram of a variation of a method for estimating biological samples and mixtures, where QC refers to quality control. [Figure 11]

[0041] This is a block diagram illustrating one variation of a method for estimating organic microspherical bodies. [Figure 12]

[0042] This is a block diagram illustrating one variation of a method for outputting organic microspherical bodies. [Figure 13]

[0043] This is a block diagram of another exemplary variation of a method for estimating organic microspheres. [Figure 14]

[0044] This image is generated by an exemplary deformation of an imaging device. [Figure 15A]

[0045] This is an image of an exemplary deformation of an organic microspherical body containing organoids at various stages of growth. [Figure 15B]

[0046] This is a plot of an exemplary variant of organoid growth within organic microspherical bodies. [Figure 16]

[0047] This is an exemplary image of a modified breast cancer organic microspheroid on day 3 compared to a conventional organoid on day 3. [Figure 17]

[0048] This is a schematic diagram of an exemplary variation that generates organic microspherical bodies containing noncellular material. [Figure 18A]

[0049] This is an exemplary deformation graph showing the derivatization of culture plates with mouse anti-laminin and / or mouse anti-collagen IV antibody via direct binding to polystyrene. [Figure 18B]

[0049] This is an exemplary modified graph showing the derivatization of culture plates with mouse anti-laminin and / or mouse anti-collagen IV antibody via protein A-mediated adhesion. [Figure 19]

[0050] This is a schematic diagram illustrating an exemplary deformation that generates organic microspherical bodies. [Modes for carrying out the invention]

[0032] Detailed explanation

[0051] Systems and methods for forming organic microspheres (e.g., droplets, droplet organic microspheres (DMOS)) are described herein. In some variations, organic microspheres can be used to screen drug compositions and predict effective treatments that may be applied to patients. For example, toxicity screening of drugs or other chemical compositions can be performed based on organic microspheres containing healthy tissue and / or cancerous (e.g., tumor) tissue from patients.

[0033]

[0052] In some variations, the organic microspheres may be configured to encapsulate one or more living cells for culture, including, but not limited to, cancer cells, stromal cells, cell lines, or combinations thereof. For example, the system and method may generate a predetermined number of cells of a predetermined size or size distribution and an organic microsphere having a predetermined concentration.

[0034]

[0053] In some variations, a set of organic microspheres can be formed from patient-derived tumor samples that have been dissociated and suspended in a basal matrix (e.g., Matrigel®). In some variations, the organic microspheres can be patterned and incubated in a microfluidic microwell array, to which one or more drug compounds can be administered. This miniaturized assay may allow for the screening of effective drugs from small tumor samples.

[0035]

[0054] As used herein, the term “organic microspheres” may refer to droplets formed from a solid or semi-solid substrate containing cells cultured to form organoids, the droplets having diameters of approximately 50 μm to 500 μm, 50 μm to 400 μm, 50 μm to 300 μm, and 50 μm to 250 μm, including all values ​​and partial ranges between them. In some variations, the substrate may include an extracellular matrix (e.g., a hydrogel such as Matrigel®). Organic microspheres may contain one, two, three, four, five, or six or more organoids. In some variations, the organic microspheres may initially contain approximately 1 to approximately 1,000 dissociated primary cells dispersed within a substrate, including all values ​​and partial ranges between, approximately 1 to approximately 750, approximately 1 to approximately 500, approximately 1 to approximately 400, approximately 1 to approximately 300, approximately 1 to approximately 200, approximately 1 to approximately 150, approximately 1 to approximately 100, approximately 1 to approximately 75, approximately 1 to approximately 50, approximately 1 to approximately 40, approximately 1 to approximately 30, and approximately 1 to approximately 20. In some variations, the organic microspheres further contain inert particles. In some variations, the inert particles are magnetic particles, magnetizable particles, fluorescent particles, or a combination thereof.

[0036]

[0055] In some variations, the system may optionally include an organic microsphere generator configured to form a set of organic microspheres from a mixture of a biological sample and a fluid. The imaging device may be configured to generate imaging data corresponding to the set of organic microspheres. A controller (e.g., a processor and memory) may be coupled to the imaging device, and the controller may be configured to receive imaging data from the imaging device and, based on the imaging data and / or other sensor data, identify a set of organic microspheres having a diameter within a predetermined range (e.g., about 50 μm to about 500 μm). For example, based on at least the imaging data, one or more properties of the set of organic microspheres may be estimated.

[0037]

[0056] The systems and methods for forming organic microspheres described herein may include one or more of the following: speed, throughput, consistency, or heterogeneity. In contrast, conventional organoids are cell aggregates derived in vitro, typically having a diameter greater than about 1 mm, and exhibit considerable variability in organoid size, shape, and cell number. Conventional organoids also require a large number (e.g., hundreds of thousands) of living cells and take a long time (e.g., one month) to culture and grow.

[0038] I. system Overview

[0057] This specification describes systems and apparatus configured to form organic microspheres. In some variations, organic microspheres may be formed based on predetermined criteria (e.g., size, number, density). The formation of organic microspheres may include one or more steps of generating, polymerizing, and demulsifying. Figure 1 is a block diagram of an organic microsphere forming system 100, which includes an organic microsphere generator 110, a sample source 130, an optional imaging device 132, a fluid source 134, a waste container 136, a polymerizer 140, a demulsifier 150, an output 152, and a computing device 160. In some variations, the organic microsphere generator 110 may include one or more microfluidic devices 112 (e.g., a microfluidic chip), a switch 114, a sensor 116, a temperature controller 118, a pump 120, or a platform 122. In some variations, the computing device 160 may include a processor 162, memory 164, communication device 166, input device 168, and display 170 (e.g., output device).

[0039]

[0058] The systems described herein offer many advantages over conventional organoid production methods. For example, cells in organic microspheres produced by the organic microsphere system 100 can establish and grow faster than cells seeded in conventional organoids. In some variations, the organic microspheres described herein can be produced at high throughput (e.g., millions per hour), and the system may be compatible with other high-throughput screening devices. Furthermore, the number of droplets seeded per well can be controlled in a predetermined manner. For example, the systems described herein may be compatible with one or more components of robotic liquid handling systems by controlling droplet size and ensuring that droplets are smaller than the bore size of the pipette tip or the channel diameter of existing technology. Components of robotic liquid handling systems generally include microplate dispensers, liquid handlers, and multi-well plates (e.g., 24-well plates, 48-well plates, 96-well plates, 1536-well plates). The systems described herein may also be compatible with other automation equipment such as vacuums, plate washers, centrifuges, incubators, imagers, microscopes, plate readers, sealers, and peelers.

[0040]

[0059] In some variations, organic microspheres can establish themselves faster than conventional organoids. For example, the local environment within an organic microsphere can promote organoid growth by facilitating the exchange of growth factors, nutrients, and other components in the culture medium (e.g., growth medium), whereas conventional organoid domes create nutrient and growth factor gradients, which dramatically affect organoid biology depending on the relative position of the organoids within the dome (e.g., center vs. periphery). As a result, dissociated tumor stem cells are less likely to encounter an environment optimized for their proliferation and reacquisition of tumor-like structures. In some variations, the organic microsphere environment can provide a homogeneous microenvironment optimized for the diffusion of key nutrients, increasing the success rate of establishment.

[0041]

[0060] The organic microspheres described herein may also possess higher heterogeneity than conventional organoids. The volume of the organic microspheres restricts each progenitor cell to a smaller volume than conventional organoids. Therefore, clonal takeover by rapidly dividing cells is limited by the size (e.g., diameter) of the organic microspheres. This property of organic microspheres can facilitate the analysis of biologically and clinically relevant subclones. Although this isolation may be lost after multiple passages, individual organic microspheres can be recovered and cultured separately, allowing for the isolation of specific subclones. The ability to separate distinct clonal populations is also useful in studies aimed at understanding molecular factors contributing to drug sensitivity and resistance. In some variations, imaging can be used to identify and isolate one or more distinct subclones.

[0042]

[0061] Cells grown within organic microspherical bodies can acquire 3D structures that better represent the source tissue or main tissue more reliably and quickly than conventional organoids. For example, the local environment within the droplet can promote the exchange of growth factors, nutrients, and other components in the culture medium, thereby promoting organoid growth. Facilitating the diffusion of nutrients throughout the relatively small spherical droplet may increase the tendency for establishment on a faster timescale.

[0043]

[0062] Organic microspheres and apparatus for forming them are described in International Patent Application PCT / US2020 / 026275, entitled “METHODS AND APPARATUSES FOR PATIENT-DERIVED MICRO-ORGANOSPHERES,” the entire disclosure of which is incorporated herein by reference in whole.

[0044]

[0063] Figure 2A is a schematic diagram of an organic microsphere forming system 200, which includes an organic microsphere generator 210, a sample source 212, a fluid source 230, an output 252, or one or more fluid conduits 216 configured to flow between the output 252 and the organic microsphere generator 210. The organic microsphere generator 210 may include a plurality of microfluidic devices 214 configured to produce organic microspheres simultaneously (e.g., in parallel operation). In some variations, the fluid source 230 may include bulk oil and / or cleaning fluid. In some variations, the output 252 may include a plurality of recovery containers configured to separately receive each output of the plurality of microfluidic devices 214.

[0045]

[0064] Figure 2B is a schematic diagram of a demulsifier 250 fluidly coupled between the polymerizer 240 and the output 252. For example, using each fluid conduit 216, the demulsifier 250 may be fluidly coupled to the output of the polymerizer 240, and the output 252 may be fluidly coupled to the output of the demulsifier 250. In some variations, the polymerizer 240 and the demulsifier 250 may be temperature-controlled to approximately 37°C.

[0046]

[0065] Figure 2C is a schematic diagram of an organic microsphere forming system 202, which includes an organic microsphere generator 210, a sample source 212, a fluid source 230, and a polymerizer 240. In some variations, the organic microsphere generator 210 may include a microfluidic device 214. The microfluidic device 214 may be fluidically coupled to the sample source 212, the fluid source 230, and the polymerizer 240 using fluid conduits 216. For example, the microfluidic device 214 may receive input from the sample source 212 and the fluid source 230 and output one or more organic microspheres to the polymerizer 240. In Figure 2C, the organic microsphere generator 210 and the polymerizer 240 are separate from each other.

[0047]

[0066] Figure 2D is a schematic diagram of an organic microsphere forming system 204, which includes an organic microsphere generator 210, a sample source 212, a fluid source 230, and a polymerizer 240. In some variations, the organic microsphere generator 210 may include a microfluidic device 214. The microfluidic device 214 may be fluidically coupled to the sample source 212, the fluid source 230, and the polymerizer 240 using fluid conduits 216. For example, the microfluidic device 214 may receive input from the sample source 212 and the fluid source 230 and output one or more organic microspheres to the polymerizer 240. In Figure 2D, the organic microsphere generator 210 and the polymerizer 240 may be coupled to each other.

[0048]

[0067] In some variations, one or more of systems 200, 202, 204, and demulsifier 250 may be pressure and temperature controlled (e.g., regulated). In some variations, one or more parts of the microfluidic device 214 may be made visible (e.g., viewable by the user, imaged by an imaging device). For example, junctions of the microfluidic device (e.g., intersections, T-junctions) may be visible for imaging. In some variations, one or more of the microfluidic devices 214 may be sterilized (e.g., washed) at predetermined intervals (e.g., after each run).

[0049]

[0068] Figure 3A is a schematic diagram of an organic microsphere forming system 300, which includes an organic microsphere generator 310, a switch 314, a sample source 330, a fluid source 334, and an output 352. In some variations, the system 300 may include a single-channel configuration, in which the organic microsphere generator 310 includes a single channel for each of the sample source 330, the fluid source 334, and the output 352.

[0050]

[0069] Figure 3B is a schematic diagram of an organic microsphere forming system 302, which includes an organic microsphere generator 310, a switch 314, a sample source 330, a fluid source 334, and an output 352. In some variations, the system 302 may include a multi-channel configuration, in which the organic microsphere generator 310 includes multiple channels for each of the sample source 330, the fluid source 334, and the output 352. The multi-channel configuration may allow for flexibility, shorter runtime, and facilitate continuous operation and cleaning between runs (e.g., washing, sterilization).

[0051]

[0070] Figure 4A is a plan view of an organic microsphere formation system 400, which includes a microfluidic device 412, a cover 413, a switch 414 (e.g., an integrated switch), a sensor 416 (e.g., an output flow sensor), a fluid source 434 (e.g., a 50 mL bulk reagent), a waste container 436 (e.g., a 50 mL waste module), an output 452 (e.g., a 1.7 mL output adapter), and a reservoir 453 (e.g., a sample reduction reservoir). Figure 4B is a perspective view of the organic microsphere formation system 400 in a closed configuration (e.g., the cover 413 is closed over the microfluidic device 412), and Figure 4C is a perspective view of the organic microsphere formation system 400 shown in an open configuration (e.g., the cover 413 is open to facilitate access to the microfluidic device 412). In some variations, the organic microsphere formation process can be performed when the cover 413 is in a closed configuration. In some variations, the open configuration facilitates operator access to the microfluidic device 412. In some variations, the cover 413 may include a transparent portion configured to allow visual access to the microfluidic device 412 (for example, for an imaging device).

[0052]

[0071] Figure 7 is an image of an exemplary variant of an organic microspheroid forming system 700, which includes a microfluidic device 712, a switch 714, a pump 720 (e.g., a fluid pump, an air pump), an imaging device 732, an output 752 (e.g., an output line), and an input device 768 (e.g., switch control).

[0053] Organic microspherical body generator

[0072] In some variations, the organic microsphere generator 110 (e.g., DMOS, generator, droplet generator) may include at least a partially enclosed enclosure (e.g., housing) in which one or more automated organic microsphere formation steps are performed. For example, the organic microsphere generator 110 may be configured to transfer a sample source 130 and a fluid source 134 to a microfluidic device 112 using one or more switches 114, a pump 120, and a platform 122. A temperature controller 118 and the pump 120 may be configured to facilitate the formation of organic microspheres in the microfluidic device 112. Optionally, one or more sensors 116 and / or imaging devices 132 may be configured to monitor the organic microsphere formation process. A computing device 160 may be configured to receive sensor data and / or imaging data and may be used to control the organic microsphere generator 110. One or more fluid conduits (e.g., connectors, tubes, connectors, lines) may flow between the microfluidic device 114 and the pump 120, sample source 130, fluid source 134, and / or waste container 136.

[0054]

[0073] In some variations, the organic microsphere generator 110 may include transparent windows and / or openings that allow visual access to the organic microsphere generation process (e.g., sample, fluid, mixture, organic microspheres).

[0055] Microfluidic devices

[0074] In some variations, the organic microsphere generator 110 may include one or more microfluidic devices 112 fluidically coupled to one or more sample sources 130 or fluid sources 134. In some variations, the organic microspheres may be formed from a single microfluidic device 114 using sample volumes ranging from about 5 μL to about 5 mL, including the full range and intermediate sub-values. In some variations, the sample volume may be about 5 μL, about 10 μL, about 20 μL, about 35.3 μL, about 50 μL, about 100 μL, about 250 μL, about 500 μL, about 1 mL, about 1.5 mL, about 2 mL, about 2.5 mL, about 3 mL, about 3.5 mL, about 4 mL, about 4.5 mL, or about 5 mL.

[0056]

[0075] In some variations, the sample may contain approximately less than 10,000 to approximately 100,000 cells, including the full range and intermediate sub-values. In some variations, the sample may contain approximately 3,500 to approximately 100,000 cells. In some variations, the sample may contain approximately 3,500 to approximately 7,500 cells.

[0057]

[0076] In some variations, the formed organic microspheres may contain concentrations of approximately 10 cells per 17 nL of organic microspheres, approximately 20 cells per 17 nL of organic microspheres, and approximately 100 cells per 17 nL of organic microspheres, including all values ​​and partial ranges in between.

[0058]

[0077] In some variations, the organic microsphere generator 110 may include multiple microfluidic devices 112 operating simultaneously, enabling higher-throughput parallel operation. In some variations, the microfluidic devices 112 may include a retractable cover configured to allow cleaning and reuse of the device 112. For example, one or more fluid channels and microfluidic devices 114 may be sterilized (e.g., washed) for reuse. In some variations, the microfluidic devices 112 may include a transparent portion configured for visual access and to allow imaging, as described in more detail herein.

[0059]

[0078] In some variations, the biological sample can be prepared in a biosafety cabinet and enclosed (e.g., sealed) within the microfluidic device 112, thereby avoiding contamination. In some variations, the microfluidic device 112 can be used in conjunction with the organic microsphere generator 110. In some variations, the microfluidic device 112 can be configured for single use (e.g., as a disposable consumable).

[0060]

[0079] Figure 5 is a cross-sectional view of an exemplary variant of a microfluidic device 500, including an input channel 512, an output channel 520, and an engagement feature 530. In some variants, the engagement feature (e.g., a notch) can be configured to fit a corresponding organic microspherical system (e.g., a housing) in a predetermined configuration. That is, the engagement feature can ensure that the microfluidic device 500 is loaded in a predetermined orientation and not in another orientation. In some variants, the microfluidic device 500 can be configured to generate organic microspherical bodies having a diameter of approximately 300 μm. In some variants, the channels 512, 520 may have a meandering shape configured to minimize the size of the device 500 while maintaining a laminar flow with a predetermined back pressure. In some variants, the larger diameter portions of the channels 512, 520 can be configured to prevent major samples (e.g., cell clumps, protein aggregates, debris) from clogging the microfluidic device 500. The microfluidic device 500 may be a single-use device or a device for multiple uses.

[0061] switch

[0080] In some variations, the organic microsphere generator 110 may include one or more switches 114 (e.g., valves) coupled to a microfluidic device 112, a sample source 130, a fluid source 134, and / or a waste container 136, configured to provide input / output control to the microfluidic device 112 and to ensure consistent processing of the sample source 130 having a repeatable output metric. In some variations, the switches 114 may be controlled by a computing device 160 and may operate, for example, in response to sensor data generated by a sensor 116 and image data generated by an imaging device 132.

[0062] sensor

[0081] In some variations, the organic microsphere generator 110 may include one or more sensors 116 configured to monitor one or more components and / or steps of the organic microsphere formation process. In some variations, one or more sensors 116 may include one or more optical sensors, mechanical sensors, voltage and / or resistance (or capacitance or inductance) sensors, force sensors, etc. In some variations, one or more sensors 116 may be configured to measure one or more parameters such as flow, pressure, pH, dissolved gas concentration, osmotic pressure, turbidity, degree of hydration, conductivity, absorbance, nutrient concentration, waste concentration, ion concentration, oxygen concentration, temperature, or combinations thereof.

[0063]

[0082] In some variations, a flow sensor coupled to the microfluidic device 112 may be configured to generate sensor data (e.g., flow rate data), which is received by a computing device 160 to control one or more organic microsphere generators 110 (e.g., a switch 114, a temperature controller 118, a pump 120), a polymerizer 140, or a demulsifier 150. For example, extracellular matrices such as Matrigel® may have a wide range of viscosity when used for organic microsphere formation, which can result in varying flow rates at a constant pressure. In some variations, the flow sensor may be configured to measure the flow rate in the microfluidic device 112. By changing the pressure in response to the measured flow rate (e.g., via the pump 120), a consistent flow rate can be maintained, thereby improving the consistency of droplet formation. In some variations, pressure and temperature can be controlled based on one or more of the sensor data and / or imaging data.

[0064]

[0083] In some variations, one or more sensors (e.g., proximity sensors) may be configured to measure the position of the enclosure of the generator 110 (e.g., open cover, closed cover). That is, a separate part of the proximity sensor may be positioned on one side of the cover (e.g., lid) to generate signals corresponding to the closed and open states.

[0065] temperature regulator

[0084] In some variations, the organic microsphere generator 110 may include one or more temperature controllers 118. The temperature controller 120 may include one or more heaters, coolers (e.g., Peltier devices), or temperature sensors coupled to one or more of the organic microsphere generator 110 (e.g., microfluidic device 112, switch 114, pump 120, fluid conduit), sample source 130, fluid source 134, polymerizer 140, or demulsifier 150. In some variations, the computing device 160 may be coupled to the temperature controller 118 and configured to control the temperature controller 118 based on, for example, sensor data and / or imaging data. In some variations, the temperature controller 118 may be configured to polymerize a temperature-activated hydrogel (e.g., Matrigel®).

[0066] pump

[0085] In some variations, the organic microsphere generator 110 may include one or more pumps 120 (e.g., fluid pumps) configured to control the fluid flow to and from the microfluidic device 112. In some variations, one or more pumps may be coupled to a fluid conduit flowing through the generator 110 and configured to produce a predetermined fluid flow rate through the generator 110 to facilitate the formation of a set of organic microspheres. In some variations, the pumps 120 may include positive displacement pumps (e.g., peristaltic pumps), centrifugal pumps, or combinations thereof. In some variations, one or more sample sources 130 may be coupled to the fluid pumps 120.

[0067]

[0086] In some variations, the pump 120 may include one or more valves. The pump 120 may be controlled in a predetermined manner by the computing device 160. For example, one or more pumps and switches may be activated sequentially in a predetermined order to ensure consistent processing of samples with repeatable output metrics. In some variations, the pump 120 may be configured to produce pressures from about 100 millibars to about 1000 millibars.

[0068] platform

[0087] In some variations, the organic microspheroid generator 110 may include one or more platforms 122 (e.g., movable stages, trays) configured to position one or more components of the generator 110 relative to each other. For example, the platform 122 may be configured to hold (e.g., fix) the microfluidic device 112 in place relative to the platform 122. The platform 122 may be further configured to move (e.g., translate along a predetermined X and / or Y axis with one or more degrees of freedom) the microfluidic device 112 to position it in place relative to a sample source 130, a fluid source 134, and an imaging device 132. Once in position, the microfluidic device 112 may receive a light beam from the imaging device 132 that can enable imaging and subsequent data processing. In some variations, the platform 122 may be configured to move the microfluidic device 112 to connect to (flow through) one or more fluid lines fluidically coupled to one or more of the sample source 130, a fluid source 134, a waste container 136, etc. Alternatively, platform 122 may be configured to move a fluid line toward a stationary microfluidic device 114.

[0069] Sample source

[0088] In some variations, the sample source 130 may include one or more cancer cells, stromal cells, cell lines, non-cancerous cells, organoids, patient-derived xenografts, cell mixtures in controlled or uncontrolled stoichiometry, single-cell suspensions, frozen tissues (e.g., biobanks), fresh excisions, biopsies (e.g., fine-needle biopsies), and extracellular matrix (ECM) (e.g., Matrigel®), combinations thereof, etc. For example, the sample may be patient-derived (e.g., for quick diagnosis to guide treatment), such as an extraction from a small patient biopsy, or derived from excised patient tissue (e.g., for high-throughput screening), including a portion of an excised primary tumor or dysfunctional organ. The sample tissue (e.g., biopsy) used to form organic microspheres (e.g., dissociated tissue) may be derived from normal, i.e., healthy living tissue, or from diseased or diseased living tissue, such as tumor-derived tissue or fluid. The tissue used for organic microspheres may include immune system cells such as T lymphocytes, B lymphocytes, polymorphonuclear leukocytes, macrophages, and dendritic cells. In some variations, the cells may be stem cells, progenitor cells, or somatic cells. In some variations, the tissue may be mammalian cells such as human cells or cells from animals such as mice, rats, rabbits, or combinations thereof. In some variations, the sample source 130 may include preadipocytes, mesenchymal stem cells (MSCs), mast cells, and adipose tissue macrophages, blood vessels, and / or microvascular fragments found within stromal vascular cell populations.

[0070]

[0089] In some variations, organic microspheroids may include, but are not limited to, one or more cell types, including neurons, cardiomyocytes, myocytes, chondrocytes, pancreatic acinar cells, islets of Langerhans, osteocytes, hepatocytes, Kupffer cells, fibroblasts, myoblasts, satellite cells, endothelial cells, adipocytes, preadipocytes, bile duct epithelial cells, and combinations thereof. Cells may be taken from one or more tissues of the following: bone marrow, skin, cartilage, tendon, bone, muscle (including cardiomyocytes), vascular, corneal, nerve, brain, gastrointestinal, kidney, liver, pancreatic (including islet cells), lung, pituitary, thyroid, adrenal, lymphoid, salivary, ovarian, testicular, cervical, bladder, endometrial, prostatic, vulvar, or esophageal tissues.

[0071]

[0090] In general, these tissues (and the cells arising therefrom) can be collected from biopsies to form organic microspheres. Therefore, the tissue may originate from a biopsy, surgical specimen, aspiration, drainage, or cell-containing fluid. Suitable cell-containing fluids include blood, lymph, sebaceous fluid, urine, cerebrospinal fluid, or ascites. For example, in patients with transperitoneal metastasis, ovarian cancer cells or colon cancer cells may be isolated from ascites. Similarly, for example, in patients with cervical cancer, cervical cancer cells may be collected from the cervix by a large excision of the transformation zone or a pyramidal biopsy. In some variations, the organic microspheres may contain multiple cell types present in the fluid of the developing tissue or site of origin. In some variations, the cells may be obtained directly from the patient without an intermediate subculturing step, or they may first go through an intermediate culture step to generate primary cultures.

[0072]

[0091] In some variations, different sample types (e.g., cells, ECM) may be placed in separate chambers (e.g., tubes, reservoirs, compartments) of the sample source 130 before mixing within the microfluidic device 112. In some variations, the sample source 130 may be set to a predetermined temperature (e.g., 4°C, approximately 4°C to approximately 8°C).

[0073]

[0092] The sample (e.g., tumor sample) can be dissociated into cells and / or cell clusters, and then the cells and / or cell clusters can be used to form organic microspheres.

[0074] Imaging device

[0093] In some variations, system 100 may include one or more imaging devices 132 configured to generate imaging data to be processed by a controller (e.g., a processor and memory). For example, an imaging device (e.g., a camera) may be configured to image one or more of the microfluidic device 112, polymerizer 140, or demulsifier 150 to monitor the organic microsphere formation process. In some variations, the properties of one or more of the mixture and / or organic microspheres can be estimated based on at least the imaging data. In some variations, system fluctuations, temperature, and / or pressure can be controlled based on at least the imaging data. For example, the pressure in the microfluidic device 112 can be changed in real time based on the size and shape of the formed organic microspheres, which are estimated from the imaging data.

[0075]

[0094] In some variations, the imaging device 132 may include a camera, a lens, an optical sensor (e.g., a charge-coupled device (CCD) or a complementary metal-oxide-semiconductor (CMOS) optical sensor), a light source, or a combination thereof. For example, the optical sensor may be a CMOS or CCD array with or without a color filter array and associated processing circuitry. In some variations, the light source (e.g., a laser, LED, lamp, etc.) may be configured to produce light that can be carried by an optical fiber cable, or the imaging device 132 may include one or more LEDs configured to provide illumination. For example, the imaging device 132 may include a bundle of flexible optical fibers (e.g., a fiberscope). The fiberscope may be configured to receive and propagate light from an external light source.

[0076]

[0095] In some variations, the imaging device 132 may include one or more microscopy techniques, such as confocal microscopy, thus enabling full-stack imaging due to the relatively small diameter of the organic microspheres compared to organoids. Some conventional biological imaging systems are limited to an imaging depth of approximately 300 μm. However, organoids typically have a depth of approximately 1 mm to 2 mm. Therefore, conventional imaging systems can only visually access about one-third or less of the organoid. In some variations, organic microspheres may have a depth of approximately 300 μm or less, enabling high-throughput imaging of the entire organic microsphere. Furthermore, the consistency of the organic microspheres described herein allows them to be aligned to a single focal plane so that a microscope (e.g., a confocal microscope) can be configured to image multiple organic microspheres simultaneously. In addition, the relatively small size (e.g., diameter) of the organic microspheres can increase the spatial density and number of organic microspheres imaged in a single field of view. For example, organic microspheres can be spherical and have a volume of about 14 nL, which is considerably smaller than organoids, which are hemispherical dome-shaped and have a volume of about 50 μL. As a result, the depth (i.e., along the z-axis of focus) of organic microspheres can be much smaller than that of organoids. Therefore, organic microspheres can be imaged using multiple stacked imaging, whereas the thickness of conventional organoids requires image acquisition in multiple planes (e.g., z-stacking) for accurate imaging. Thus, the speed and throughput of conventional organic microsphere imaging can be improved compared to organoid imaging. Figure 14 is an image 1400 of a set of identified organic microspheres 1410 using the imaging device described herein. Figure 14 shows a set of cells evenly distributed within each droplet.

[0077] fluid source

[0096] In some variations, the organic microspherical system 100 may include, but is not limited to, one or more fluid sources 134, including extracellular matrix proteins (e.g., fibronectin), drugs (e.g., small molecules), peptides, antibodies (e.g., those that regulate cell survival, proliferation, or differentiation), inhibitors of specific cellular functions, reagents, miscible materials (e.g., hydrophobic substances, oils), natural gels, synthetic gels (e.g., hydrogels), fluid matrix materials, and combinations thereof.

[0078]

[0097] In some variations, the fluid matrix material may be configured to form support or support networks of dissociated cells dispersed within the fluid matrix material. In some variations, the fluid matrix material may include one or more polymers and hydrogels, including collagen, fibrin, chitosan, Matrigel®, polyethylene glycol, and dextran, which is chemically crosslinkable or photocrosslinkable, as well as electrospun biological, synthetic, or biosynthetic blends. For example, the matrix material may be a gel containing type I collagen, such as type I collagen obtained from rat tails. In some variations, the gel may be a pure type I collagen gel, or a gel containing type I collagen in addition to other components, such as other extracellular matrix proteins. Synthetic gels may refer to gels that are not of a naturally occurring nature. Examples of synthetic gels include gels derived from polyethylene glycol (PEG), polyhydroxyethyl methacrylate (PHEMA), polyvinyl alcohol (PVA), polyethylene oxide (PEO), etc.

[0079]

[0098] In some variations, the hydrogel may include polymer materials, such as, but not limited to, alginic acid, collagen (including collagen types I and VI), elastin, keratin, fibronectin, proteoglycans, glycoproteins, polylactides, polyethylene glycol, polycaprolactone, polycolides, polydioxanone, polyacrylates, polyurethanes, polysulfones, polypeptide sequences, proteins and their derivatives, oligopeptides, gelatin, elastin, fibrin, laminin, polymethacrylates, polyacetates, polyesters, polyamides, polycarbonates, polyanhydrides, polyamino acid carbohydrates, polysaccharides and modified polysaccharides, as well as their derivatives and copolymers, and inorganic materials such as glass (including bioactive glass), ceramics, silica, alumina, calcite, hydroxyapatite, calcium phosphate, bone, and combinations thereof.

[0080]

[0099] In some variations, the fluid source 134 may include one or more temperature-controlled compartments. In some variations, the number and quantity of fluid may be sufficient to supply multiple production runs. For example, cell loading may ensure that the fluid source level is sufficient for each run performed.

[0081] Waste containers

[0100] In some variations, the organic microsphere system 100 may include one or more waste containers 136 fluidly coupled to the organic microsphere generator 110 and / or demulsifier 150. The waste containers 136 may be configured to contain waste products from the organic microsphere formation process, such as oil and / or other waste products from the demulsifier 150.

[0082] Polymerizer

[0101] In some variations, the organic microsphere system 100 may include one or more polymerizers 140 coupled to the output of a microfluidic device 112 and configured to polymerize a mixture (e.g., droplets) to form a set of organic microspheres (e.g., droplet organic microspheres). Polymerization of the mixture can increase stability before demulsification. In some variations, the polymerizer 140 may be configured to heat the mixture to a predetermined temperature (e.g., about 37°C, about 10°C to about 40°C) for a predetermined time. In some variations, the polymerizer 140 may be integrated with the microfluidic device 112 or may be separate. For example, the microfluidic device 112 may be configured to form the mixture at a temperature of about 4°C. The mixture may flow into the polymerizer 140 (e.g., a heating chamber) within the microfluidic device 112. The polymerizer 140 may be configured to polymerize the mixture at about 37°C using a heater of a temperature controller 118. For example, the temperature controller 118 may be coupled to a heat-conducting material surrounding the polymerizer 140 to evenly distribute heat to the mixture. The polymerizer 140 may include one or more temperature sensors configured to generate sensor data in a closed-loop control of the organic microsphere formation process. Additionally or alternatively, the polymerizer 140 may include chemical polymerization (e.g., polymerizing the mixture using calcium).

[0083] demulsifier

[0102] In some variations, the organic microsphere system 100 may include one or more demulsifiers 150. In some variations, the organic microspheres formed after polymerization may be immersed in a fluid such as oil, which can be removed by the demulsifier 150. After separation from the oil, a growth medium may be introduced into the organic microspheres. In some variations, the demulsifier 150 may include a separate microfluidic device configured to filter the polymerized droplet organic microspheres from the oil and introduce them into a growth (e.g., cell culture) medium.

[0084]

[0103] Figure 6A is a schematic diagram of a demulsifier 600 based on magnetic separation. The demulsifier 600 may include a first inlet 610A (e.g., an inlet for oil and organic microspheres), a first outlet 612A (e.g., an outlet for oil and waste), a second inlet 620A (e.g., an inlet for growth medium and washing solution), and a second outlet 622A (e.g., an outlet for growth medium and organic microspheres). The first inlet 610A and the second inlet 620A may be located on the first side of the demulsifier 600, and the first outlet 612A and the second outlet 622A may be located on the second side of the demulsifier 600 opposite the first side. In some variations, a mixture of a first fluid (e.g., oil) and polymerized organic microspheres 650 may be received at the first inlet 610A. A second fluid (e.g., growth medium, washing solution, aqueous solution) can be received at a second inlet 620A. The demulsifier 600 may be configured for laminar flow so that the aqueous solution from the second inlet 620A and the hydrophobic oil from the first inlet 610A do not mix within the demulsifier 600, as shown in Figure 6A. Instead of mixing, the first flow stream 630A (e.g., oil flow stream) and the second flow stream 632A (e.g., aqueous flow stream) are configured to flow in parallel through the demulsifier 600. In some variations, the demulsifier 600 may have a magnet 640 that functions as a flow separator configured to separate organic microspherical bodies 650 containing magnetic nanoparticles from the first flow stream 630A (e.g., oil flow stream). In some variations, the magnet 640 may be configured to extend along a predetermined length of the demulsifier 600. As the organic microspheres 650 flow through the demulsifier 600, the magnet 640 may be configured to separate the organic microspheres 650 from the first flow stream 630A (e.g., an oil flow stream) and the second flow stream 632A (e.g., an aqueous flow stream).

[0085]

[0104] Figure 6B shows a demulsifier 602 configured to filter polymerized droplets from oil into a culture medium using laminar flow and small microstructures (e.g., micropillars). The demulsifier 602 may include a first inlet 610B (e.g., an inlet for oil and organic microspheres), a first outlet 612B (e.g., an outlet for oil and waste), a second inlet 620B (e.g., an inlet for growth medium and washing solution), and a second outlet 622B (e.g., an outlet for growth medium and organic microspheres). The first inlet 610B and the second inlet 620B may be located on the first side of the demulsifier 602, and the first outlet 612B and the second outlet 622B may be located on the second side of the demulsifier 602 opposite the first side. In some variations, a mixture of the first fluid (e.g., oil) and polymerized organic microspheres 650 may be received at the first inlet 610B. A second fluid (e.g., growth medium, washing solution, aqueous solution) can be received at a second inlet 620B. In some variations, the demulsifier 602 may be configured for laminar flow so that the aqueous solution from the second inlet 620B and the hydrophobic oil from the first inlet 610B do not mix within the demulsifier 602, as shown in Figure 6B. Instead of mixing, the first flow stream (e.g., oil flow stream (not shown)) and the second flow stream (e.g., aqueous flow stream (not shown)) flow in parallel through the demulsifier 602. In some variations, the demulsifier 602 may have a flow separator 660 (e.g., a set of micropillars, shown as gray circles in Figure 6B) configured to separate organic microspheres 650 (shown as white circles in Figure 6B) from the first flow stream (e.g., oil flow stream). The flow separator 660 may be configured to extend along a predetermined length of the demulsifier 602. As the organic microspheres 650 flow through the demulsifier 602, the micropillars of the flow separator 660 may be configured to separate the organic microspheres 650 from a first flow stream (e.g., an oil flow stream) and a second flow stream (e.g., an aqueous flow stream).In some variations, the micropillars can be positioned at an angle of approximately 1 degree from a first flowstream (e.g., an oil flowstream) to a second flowstream (e.g., an aqueous flowstream), thereby forcing the organic microspheres 650 from the first to the second flowstream while maintaining parallel flow in each flowstream. The spacing of the micropillars can be such that the organic microspheres 650 cannot pass through them, and the spacing can be modified during fabrication depending on the expected droplet size.

[0086]

[0105] At the tip of the demulsifiers 600 and 602, a first flowstream may be configured to flow through a first outlet 612A or 612B, and a second flowstream may be configured to flow through second outlets 622A and 622B. In some variations, the first outlet 612A or 612B may flow to a waste container (not shown), and the second outlet 622A or 622B may flow to an output (e.g., a collection container), facilitating the recovery of a high proportion of the formed organic microspheres. In contrast to conventional demulsification methods, the demulsifiers 600 or 602 described herein may be configured to automatically demulsify organic microspheres without manual handling or centrifugation.

[0087]

[0106] In some variations, demulsification may be based on a serial supernatant assay. In some variations, individual organic microspheres in a well (e.g., a 96-well plate) may be cultured to allow for fractionation of the supernatant at predetermined intervals. The collected supernatants may be assayed separately.

[0088] output

[0107] In some variations, the organic microsphere system 100 may include one or more outputs 152 (e.g., containers, collectors, wells, assays, or recovery containers) configured to receive the formed organic microspheres. In some variations, a predetermined number of organic microspheres may be dispensed into multiple wells. In some variations, the outputs 152 may be configured to bind to the organic microspheres. For example, the organic microspheres may adhere strongly to a predetermined portion of the well (e.g., a predetermined location at the bottom of the well), thereby enabling high-throughput processing such as rapid medium exchange and fixed imaging with increased resistance to one or more chemical and mechanical processes.

[0089]

[0108] In some variations, the output 152 (e.g., a well plate) may have one or more coatings and textures (e.g., patterns). In some variations, the bottom surface of the wells may be coated and / or patterned to facilitate the adhesion of organic microspheres to the bottom surface. For example, a nonspecific antibody may adhere to the bottom of the plate if it has an affinity for other materials or molecules that form a scaffold for the organic microspheres. Thus, organic microspheres that come into contact with the antibody may bind strongly to the bottom of the plate. In some variations, one or more plastics may be placed on the surface of the output (e.g., the bottom of the wells) and configured to adhere to (e.g., bind to) the organic microspheres.

[0090] Computing devices

[0109] In some variations, system 100 may include a computing device 160 that includes a controller (e.g., a processor 162, memory 164), a communication device 166, an input device 168, a display 170, or a combination thereof. The computing device 160 may be configured to control (e.g., operate) system 100. The computing device 160 may include multiple devices. For example, an organic microsphere generator 110 may enclose one or more components of the computing device 160 (e.g., a processor 162, memory 164, communication device 166), while one or more components of the computing device 160 may be provided remotely from the organic microsphere generator 110 (e.g., an input device 168 or a display 170).

[0091]

[0110] In some variations, the controller may be configured to receive imaging data corresponding to one or more of a mixture or a set of organic microspheres and to estimate the properties of one or more of the set of organic microspheres based on at least the imaging data. In some variations, the controller may be configured to receive imaging data corresponding to a set of organic microspheres and to identify a set of organic microspheres having a diameter of approximately 50 μm to approximately 500 μm based on at least the imaging data.

[0092]

[0111] In some variations, the controller may be configured to estimate the number of organic microspheroids in multiple wells, at least based on imaging data.

[0093]

[0112] In some variations, the controller may be configured to receive sensor data from one or more sensors and to estimate the properties of one or more of a set of organic microspheres based on at least the sensor data. In some variations, the controller may be configured to modify one or more of the pumps or temperatures based on at least the imaging data and sensor data.

[0094]

[0113] In some variations, the controller may be configured to estimate one or more properties of the mixture based on imaging data. For example, one or more properties of the mixture may include the total number of cells and the number of living cells. In some variations, the controller may be configured to estimate one or more properties of the biological sample based on imaging data. For example, one or more properties of the biological sample may include the total number of cells and the number of living cells.

[0095]

[0114] In some variations, the controller may be configured to receive imaging data corresponding to the characteristics of one or more cells or one or more cells within one or more organic microspherical bodies.

[0096] Processor

[0115] A processor as described herein (e.g., processor 162) may process data and / or other signals to control one or more components of a system (e.g., organic microsphere generator 110, imaging device 132, or computing device 160). The processor may be configured to receive, process, compile, compute, store, access, read, write, and / or transmit data and / or other signals. Additionally or alternatively, the processor may be configured to control one or more components of a device and / or one or more components of a computing device (e.g., console, touchscreen, personal computer, laptop, tablet, server).

[0097]

[0116] In some variations, the processor may be configured to access or receive data and / or other signals from an organic microsphere generator 110, an imaging device 132, a server, a computing device 160, or a storage medium (e.g., memory, flash drive, memory card, database). In some variations, the processor may be any suitable processing device configured to run and / or execute a set of instructions or code, and may include one or more data processors, image processors, graphics processing units (GPUs), physical processing units, digital signal processors (DSPs), analog signal processors, mixed signal processors, machine learning processors, deep learning processors, finite state machines (FSMs), compression processors (e.g., data compression to reduce data rate and / or memory requirements), cryptographic processors (e.g., for secure wireless data transfer), and / or central processing units (CPUs). The processor may be, for example, a general-purpose processor, a field-programmable gate array (FPGA), an application-specific integrated circuit (ASIC), a processor board, etc. The processor may be configured to run and / or execute application processes and / or other modules, system-related processes, and / or functions. The underlying device technologies can be provided in a variety of component types (e.g., metal-oxide-semiconductor field-effect transistor (MOSFET) technologies such as complementary metal-oxide-semiconductor (CMOS), bipolar technologies such as emitter-coupled logic (ECL), polymer technologies (e.g., silicon-conjugated polymers and metal-conjugated polymer-metal structures), analog and digital hybrids, etc.).

[0098]

[0117] The systems, devices, and / or methods described herein may be implemented by software (executed in hardware), hardware, or a combination thereof. Hardware modules may include, for example, general-purpose processors (or microprocessors or microcontrollers), field-programmable gate arrays (FPGAs), and / or application-specific integrated circuits (ASICs). Software modules (executed in hardware) may be expressed in a variety of software languages ​​(e.g., computer code), including structured text, TypeScript, C, C++, C#, Java®, Python, Ruby, Visual Basic®, and / or other object-oriented, procedural, or other programming languages ​​and development tools. Examples of computer code, though not limited to, include microcode or microinstructions, machine instructions such as those generated by a compiler, code used to generate web services, and files containing higher-level instructions executed by a computer using an interpreter. Additional examples of computer code, though not limited to, include control signals, encrypted code, and compressed code.

[0099] memory

[0118] The organic microspherical systems and devices described herein may include a memory (e.g., memory 164) configured to store data and / or information. In some variations, the memory may include one or more of the following: random access memory (RAM), static RAM (SRAM), dynamic RAM (DRAM), memory buffer, erasable programmable read-only memory (EPROM), electrically erasable read-only memory (EEPROM), read-only memory (ROM), flash memory, volatile memory, non-volatile memory, or combinations thereof. In some variations, the memory may store instructions causing a processor to execute modules, processes, and / or functions associated with devices such as image processing, image display, sensor data, data and / or signal transmission, data and / or signal reception, and / or communication. Some variations described herein may relate to computer storage products having a non-temporary computer-readable medium (sometimes called a non-temporary processor-readable medium) having instructions or computer code that perform various computer operations. Computer-readable media (or processor-readable media) are non-transient in the sense that they do not themselves contain transient propagating signals (e.g., electromagnetic waves that propagate and carry information over a transmission medium such as space or a cable). Computer code (sometimes called code or algorithms) may be designed and built for one or more specific purposes. In some variations, memory may be configured to store any data received and / or generated by computing devices and / or imaging devices. In some variations, memory may be configured to store data temporarily or permanently.

[0100] Input device

[0119] In some variations, the display may include and / or be operablely coupled an input device 168 (e.g., a touchscreen) configured to receive input data from a user. For example, user input to the input device 168 (e.g., a keyboard, buttons, or touchscreen) may be received and processed by the system 100's processor (e.g., processor 162) and memory (e.g., memory 164). The input device may include at least one switch configured to generate user reception. For example, the input device may include a touch surface for the user to provide input corresponding to user input (e.g., touch of a finger on the touch surface). The input device including the touch surface may be configured to detect contact and movement to the touch surface using one of a plurality of touch-sensitive techniques, including capacitive, resistive, infrared, optical imaging, dispersed signaling, acoustic pulse recognition, and surface acoustic wave techniques. A variation of an input device including at least one switch may have at least one of the following: a button (e.g., a hard key, a soft key), a touch surface, a keyboard, an analog stick (e.g., a joystick), a directional pad, a mouse, a trackball, a jog dial, a step switch, a rocker switch, a pointer device (e.g., a stylus), a motion sensor, an image sensor, and a microphone. The motion sensor may receive user motion data from an optical sensor and classify user gestures as user input. The microphone may receive audio data and recognize user voice as user input.

[0101]

[0120] In some variations, the organic microspherical system may optionally include one or more output devices, such as an audio device and a haptic device, in addition to the display. The audio device may audibly output any system data, alarms, and / or notifications. For example, the audio device may output an audible alarm if a malfunction is detected. In some variations, the audio device may include at least one of a speaker, a piezoelectric audio device, a magnetostrictive speaker, and / or a digital speaker. In some variations, a user may communicate with other users using the audio device and communication channels. For example, a user may form an audio communication channel (e.g., a VoIP call).

[0102]

[0121] As an addition or alternative, the system may include a haptic device configured to provide the user with additional sensory output (e.g., force feedback). For example, the haptic device may generate a tactile response (e.g., vibration) to confirm user input to an input device (e.g., a touch surface). As another example, haptic feedback may indicate that user input is being overridden by the processor.

[0103] Communication devices

[0122] In some variations, the computing device may include a communication device (e.g., communication device 166) configured to communicate with other computing devices and one or more databases. The communication device may be configured to connect the computing device to another system (e.g., the Internet, a remote server, a database) via a wired or wireless connection. In some variations, the system may communicate with other devices via one or more wired and / or wireless networks. In some variations, the communication device may include a radio frequency receiver, transmitter, and / or optical (e.g., infrared) receiver and transmitter configured to communicate with one or more devices and / or networks. The communication device may communicate via wired and / or wireless connections.

[0104]

[0123] A communication device may include an RF circuit configured to receive and transmit RF signals. The RF circuit may convert electrical signals to and from electromagnetic signals and communicate with communication networks and other communication devices via electromagnetic signals. The RF circuit may include, but is not limited to, antenna systems, RF transceivers, one or more amplifiers, tuners, one or more oscillators, digital signal processors, CODEC chipsets, subscriber identification module (SIM) cards, memory, and other well-known circuits that perform these functions.

[0105]

[0124] Wireless communication through any device may use, but is not limited to, multiple communication standards, protocols, and technologies, including, but are not limited to, Global System for Mobile Communications (GSM), Enhanced Data GSM Environment (EDGE), High-Speed ​​Downlink Packet Access (HSDPA), High-Speed ​​Uplink Packet Access (HSUPA), Evolution Data Only (EV-DO), HSPA, HSPA+, Dual-Cell HSPA (DC-HSPADA), Long-Term Evolution (LTE), Near Field Communication (NFC), Wideband Code Division Multiple Access (W-CDMA), Code Division Multiple Access (CDMA), Time Division Multiple Access (TDMA), Bluetooth, and Wireless. Fidelity (Wi-Fi) (e.g., IEEE 802.11a, IEEE 802.11b, IEEE 802.11g, IEEE 802.11n, etc.), Voice over Internet Protocol (VoIP), Wi-MAX, protocols for email (e.g., Internet Message Access Protocol (IMAP) and / or Post Office Protocol (POP)), instant messaging (e.g., Extensible Messaging and Presence Protocol (XMPP), Session Initiation Protocol for Instant Messaging and Presence Event Package (SIMPLE), Instant Messaging and Presence Service (IMPS)), and / or Short Message Service (SMS), EtherCAT, OPC Integrated Architecture, or any other suitable communication protocol. In some variations, the devices described herein may communicate directly with each other without transmitting data over a network (e.g., via NFC, Bluetooth, WiFi, RFID, etc.).

[0106]

[0125] In some variations, the systems, devices, and methods described herein may communicate with other wireless devices via one or more networks, each of which may be any type of network (e.g., wired network, wireless network). The communication may or may not be encrypted. A wireless network may refer to any type of digital network not connected by any kind of cable. Examples of wireless communication in a wireless network include, but are not limited to, cellular communications, radio communications, satellite communications, and microwave communications. However, wireless networks may be connected to wired networks to interface with the Internet, other carriers' voice and data networks, business networks, and personal networks. Wired networks typically run via twisted-pair copper cables, coaxial cables, and / or fiber optic cables. Many different types of wired networks exist, including wide area networks (WANs), metropolitan area networks (MANs), local area networks (LANs), Internet area networks (IANs), campus area networks (CANs), global area networks (GANs) such as the Internet, and virtual private networks (VPNs). Hereinafter, "network" refers to any combination of wireless, wired, public, and private data networks that are typically interconnected via the Internet to provide integrated networking and information access systems.

[0107]

[0126] Cellular communications may encompass technologies such as GSM, PCS, CDMA or GPRS, W-CDMA, EDGE or CDMA2000, LTE, WiMAX, and 5G networking standards. Some wireless network deployments combine networks from multiple cellular networks or use a mixture of cellular, Wi-Fi, and satellite communications.

[0108] display

[0127] Image data can be output to a display (e.g., display 170) of the organic microsphere system 100. In some variations, the display may include at least one of light-emitting diodes (LEDs), liquid crystal displays (LCDs), electroluminescent displays (ELDs), plasma display panels (PDPs), thin-film transistors (TFTs), organic light-emitting diodes (OLEDs), electronic paper / e-ink displays, laser displays, and / or holographic displays. In some variations, the display 170 may be integrated as a touch screen of the organic microsphere generator 110.

[0109] II. Method

[0128] This specification describes methods for forming organic microspheres using automated organic microsphere systems and devices described herein. For example, organic microspheres can be formed, identified, and estimated in a single end-to-end integrated workflow including microfluidic and macrofluidic elements. Furthermore, identified organic microspheres can be precisely distributed based on one or more organic microsphere properties, enabling, for example, rapid drug screening. Figure 8 is a flowchart outlining one variation of a method for forming organic microspheres. Method 800 may include dissociating cells from a sample (e.g., a patient-derived tissue sample) (802). In some variations, cells may be dissociated using one or more methods such as mechanical digestion, enzymatic digestion, or a combination thereof. Any tissue type can be processed. In some variations, cells may be mixed to form, for example, a mixture of cells and a Matrigel®-based mixture. In some variations, cells may be mixed to form cells and any alternative to Matrigel as described herein.

[0110]

[0129] In some variations, one or more cellular properties can be estimated and / or identified according to step 804. For example, a portion of the dissociated cells can be stained (e.g., AO / PI) to estimate the number of viable and dead cells. These cellular estimates allow for the formation of organic microspheres at a predetermined concentration (e.g., a predetermined number of viable cells per unit volume). By estimating cellular properties such as seeding density from a sample, samples with a dead cell count (or density) exceeding a predetermined threshold can be rejected. In some variations, organic microspheres with a predetermined number of viable cells can be formed based on concentration and by controlling the size (e.g., diameter) of the formed organic microspheres. The number of viable cells can be used to determine the amount of fluid matrix material needed to form a mixture of a predetermined concentration.

[0111]

[0130] In some modifications, a set of organic microspheres may be formed according to step 806. In some modifications, cells may undergo encapsulation to form droplets of a mixture having a predetermined spatial distribution. In some modifications, the size of the droplets (e.g., diameter) may be controlled to form organic microspheres containing a predetermined number of cells and a predetermined concentration (e.g., based on temperature and pressure).

[0112]

[0131] In some variations, one or more organic microspheroid properties can be estimated and / or identified according to step 808. In some variations, the number of organic microspheroids per unit volume can be estimated. The estimation can be used to ensure that the cell type composition and the expected number of viable cells meet predetermined criteria, and to control the number of cells per droplet after encapsulation. For example, a portion of the formed organic microspheroids can be stained (e.g., AO / PI staining) to identify the number of live and dead cells. Figures 10 and 11 show variations of the estimation process for dissociated cells and droplets, as will be described in more detail herein. In some variations, the formation of organic microspheroids can correspond to a Poisson sampling distribution of the number of cells per droplet. In some variations, a set of organic microspheroids can be agitated in solution while imaging, thereby improving the estimation of organic microspheroid properties.

[0113]

[0132] In some variations, a set of organic microspheres may be output according to step 810. For example, a set of organic microspheres may be used for drug assay plating. In some variations, Poisson sample distribution may be enabled by one or more stirring or controlled dispensing in one or more containers (e.g., wells, receptacles, containers). Figure 12 shows one variation of the stirring and dispensing process, as will be described in more detail herein. In some variations, imaging data of the wells may be generated to estimate, for example, the number and location of the output organic microspheres as a baseline. In some variations, the number of droplets per well may be used to normalize the quantitative assay results. In some variations, if the number of droplets in a well does not meet a predetermined range, one or more wells may be rejected.

[0114]

[0133] In some variations, the organic microspheres may be agitated to ensure uniform distribution of the suspension in the growth medium while the organic microspheres are dispensed, for example, into a well plate (e.g., assay wells in a cell culture vessel, 6-well plates to 1536-well plates). For example, uniform distribution of the organic microspheres can be ensured by shaking the flask, manual pipetting, rocking, etc. In some variations, a set of organic microspheres may be dispensed using one or more pipetting operations or liquid handlers. For example, a liquid handler may be configured to pipet directly from the agitated container containing the organic microspheres.

[0115]

[0134] In some variations, the establishment characteristics of one or more organic microspheroids can be estimated according to step 812. For example, the establishment of a set of organic microspheroids can be confirmed by imaging at periodic intervals, allowing for the initiation of a drug assay within approximately 2 to 8 days after seeding the organic microspheroids, for example, based on predetermined criteria. In contrast, drug screening using conventional organoids can take approximately 6 to 8 weeks to generate and form organoids with a sufficient number of cells to test for drug response, which can be time-consuming and expensive, especially as a diagnostic tool. In some variations, the organic microspheroids described herein can provide drug assay results in less than 2 weeks. Figure 13 shows one variation of the estimation process for droplets placed in a well, which will be described in more detail herein.

[0116]

[0135] In some variations, the imaging data may be configured to generate imaging data for a set of wells (e.g., each well in a well plate). The processor may be configured to estimate the surface area and volume of cells over time based on the imaging data using one or more computer vision techniques. For example, the established characteristics of organic microspheres may include one or more of the organic microsphere size, volume, or growth rate. In some variations, the organic microspheres may be defined by one or more predetermined thresholds (e.g., median area of ​​70 μm²). 2 It can be identified as one established based on (twice the initial cell mass).

[0117]

[0136] In some variations, the imaging data can be analyzed to identify one or more objects within each organic microsphere that have a diameter larger than a predetermined threshold (e.g., the expected diameter of a single cell). Thus, only multicellular or organoid bodies can be identified. For example, the surface area (e.g., μm) of each object identified within each organic microsphere. 2 This method can estimate and track the time course (e.g., several hours, several days). This technique can generate quantitative data with high sensitivity, determine the establishment of the condition, and enable drug dosage administration.

[0118]

[0137] In some variations, organic microspheres can form in less than one day and become established in about two to eight days after formation. Drug assays using organic microspheres can be performed in four days or less, thereby enabling diagnosis of the organ in less than fourteen days using the systems and methods described herein.

[0119]

[0138] Figure 9 is a flowchart outlining one variation of a method for forming organic microspheres. In some variations, method 900 may include dissociating cells from a sample (e.g., a patient-derived tissue sample) according to step 902. For example, the sample may be dissociated mechanically and / or chemically (e.g., enzymatically). Mechanical dissociation may include breaking the connections between bound cells, for example, by using a surgical scalpel or scissors or by using a machine such as a homogenizer. Chemical dissociation may include breaking the connections between bound cells by treating the cells with one or more enzymes, for example, any of collagenases, dispases, DNAases, and / or hyaluronidases. One or more enzymes may be used under different reaction conditions, such as a water bath at 37°C or incubation at room temperature.

[0120]

[0139] In some modifications, the dissociated tissue can be processed to remove dead cells, dying cells, and / or cellular debris. Removal of such dead and / or dying cells may involve one or more methods, such as beads, filtration, antibody methods, or combinations thereof. For example, apoptotic cells can be separated from living cells by binding biotin to streptavidin magnetic beads after annexin V-biotin binding.

[0121]

[0140] In some variations, the sample from the patient may be from a biopsy (e.g., using a biopsy needle or puncture). For example, a biopsy may be taken using a needle of 14 gauge, 16 gauge, 18 gauge, etc., which can be inserted into the patient's tissue to extract the biopsy sample.

[0122]

[0141] In some variations, the dissociated cells may be suspended in a carrier material. In some variations, the carrier material may include a fluid matrix material. In some variations, the carrier material may be a material having a viscosity level configured to slow the sedimentation of cells in the cell suspension before polymerization and formation of organic microspheres. In some variations, the carrier material may have sufficient viscosity to keep the dissociated biopsy tissue cells suspended in the suspension until polymerization. In some variations, a non-polymerizing material may be flowed or stirred to keep the cells suspended and / or dispersed as desired.

[0123]

[0142] In some variations, a set of dissociated cells may be selected for analysis according to step 904. In some variations, one or more characteristics of the selected set of dissociated cells may be estimated according to step 906. For example, as shown in method 1000 in Figure 10, a selected set (e.g., subset) 1002 of dissociated cells may be counted and stained using one or more live / dead stains (1004). Non-limiting examples of live / dead stains include calcein AM (live), ethidium homodimer (dead), trypan blue (live), Hoechst (nucleus), and acridine orange (AO) and propidium iodide (PI) (AO / PI). AO / PI is a fluorescence-based cell viability assay in which live cells emit green fluorescence (e.g., 526 nm maximum emission wavelength) and dead cells emit red fluorescence (e.g., 617 nm maximum emission wavelength). Assay output 1006 may include the total number of cells in the patient's cell sample, the total number of viable cells, and the total number of dead cells.

[0124]

[0143] In some variations, according to step 908, one or more organic microspheroid formation parameters may be set based on the estimated characteristics of a set of dissociated cells. For example, the results of method 1000 in Figure 10 may be used to inform the organic microspheroid formation parameters of method 1010, thereby enabling a predetermined number of viable cells 1012 to be mixed with a predetermined amount of fluid so that a target number of viable cells are placed within each organic microspheroid 1014. The organic microspheroid formation parameters may include one or more such as fluid flow rate, temperature, and pressure.

[0125]

[0144] In some variations, according to step 910, the dissociated cells may be combined with a fluid matrix material to form a mixture (e.g., a non-polymerized mixture). For example, the mixture may contain dissociated cells suspended within the mixture. In some variations, the cells may remain suspended at a given temperature (e.g., about 1°C to about 210°C) and remain non-polymerized. The non-polymerized mixture may be dispensed as droplets into an immiscible material such as oil. The size and shape of the droplets may correspond to the size and shape of the organic microspheres formed. For example, uniformly sized droplets can be formed by coupling a flow of the non-polymerized material with one or more (e.g., two converging) flows of an immiscible material (e.g., oil), such that the flow rate and / or pressure of the two flows when the non-polymerized material intersects with the immiscible material can determine how droplets of the non-polymerized material are formed.

[0126]

[0145] In some variations, the size (e.g., diameter) of organic microspheres can be controlled based on one or more of the pressure in the system or the viscosity of the material. A change in either parameter will alter the consistency of the size (e.g., diameter) of the organic microspheres formed. For example, when various liquids (e.g., cellular and fluid matrix materials) reach an intersection (e.g., a T-junction) and combine, it takes time for the pressure to stabilize across the system. A change in pressure will result in variations in droplet size. For example, bubbles (e.g., microfluidic cracks) introduced into a microfluidic generator can change the pressure in the system, and consequently, the size (e.g., diameter) of the organic microspheres formed.

[0127]

[0146] As an addition or alternative, one or more droplets may be formed by printing (e.g., printing droplets onto a surface). For example, droplets may be printed onto a surface such as a flat or molded surface and polymerized. In some variations, droplets may be formed using an automated dispenser (e.g., a pipette device) configured to release a predetermined amount of nonpolymerized mixture onto a surface, into the air, and / or into a liquid medium (including an immiscible fluid).

[0128] Introduction of noncellular objects into organic microspheres

[0147] As an addition or alternative, step 910 may include forming a mixture by combining one or more noncellular objects. For example, an organic microsphere may contain one or more noncellular objects. In some variations, the noncellular objects may be added to the cellular mixture before the formation of the organic microsphere. In some variations, the noncellular objects may also be incorporated into the organic microsphere after its formation. In some variations, the noncellular objects may include inert particles.

[0129]

[0148] In some variations, each organic microsphere can contain approximately 1 to 10,000 noncellular objects, for example, approximately 10 to 7,500, approximately 10 to 5,000, or approximately 100 to 2,500 noncellular objects.

[0130]

[0149] In some variations, non-cellular objects can function as identifiers (e.g., barcodes) for identifying organic microspheres. Without any means of identifying organic microspheres, matching the organic microspheres in a first set of images and a second set of images for time-lapse imaging can be difficult or impossible when a particular well is imaged before and after the organic microspheres move. Therefore, introducing identifiers to the organic microspheres can resolve this problem and enable time-lapse imaging. In some variations, the non-cellular objects added as identifiers do not affect the biological processes.

[0131]

[0150] In some variations, the noncellular object may include particles of different sizes, light emitters, fluorophores, fluorescent particles, color particles, magnetic particles, and / or magnetizable particles. As shown in Figure 17, in some variations, a highly variable source of type A particles 1710 (e.g., magnetic particles and / or magnetizable particles) and / or type B particles 1720 (e.g., particles of different sizes, light emitters, fluorophores, fluorescent particles, and / or color particles) may be introduced into a mixture of type C particles 1730 (e.g., cells, cell mixtures, biologically active components) before the formation of the organic microspheres to generate a unique identifier (e.g., a barcode). For example, probabilistic sampling of type A particles and / or type B particles during the mixing process may generate a uniquely identifiable combination of type A particles and / or type B particles in each organic microsphere, which effectively functions as a unique identifier for each organic microsphere. Combinations of type A, type B, and type C particles can be combined in an extracellular matrix / hydrogel 1740 for organic microspheroid generation 1750 to produce multiple sets of organic microspheroids 1760, 1762, 1764. One or more identifiers can be read by a microscopy system and decoded visually or algorithmically, thereby enabling various other applications such as tracking a single organic microspheroid across multiple workflows, reformatting steps, mechanical manipulation, and flow cytometry. In some applications, the identifiers enable high-throughput sorting of organic microspheroids.

[0132]

[0151] In some variations, the magnetic particles may include one or more ferromagnetic, paramagnetic, or other types of magnetic particles. In some variations, the magnetic particles may include Fe3O4. For example, the magnetic particles can enable the mechanical manipulation and control of organic microspheres through the use of magnets, thereby increasing efficiency and capability in various steps of the workflow, such as phase separation / demulsification, rapid medium exchange, and concentration of organic microspheres to specific locations. For example, the magnetic particles can concentrate organic microspheres as a monolayer at the bottom of a well or culture plate for imaging, in the center of a well or culture plate for imaging of one or more organic microspheres, and / or at specific locations to facilitate the recovery of a set of organic microspheres.

[0133]

[0152] Cell encapsulation can take various forms. In a first variation, a single-cell suspension may be added to an extracellular matrix to form organic microspheres containing a predetermined number of cells diffused across a droplet. In a second variation, cells may be encapsulated in multiple steps to create a high-density core of cells within a larger extracellular matrix droplet. In these variations, single cells may be resuspended in the extracellular matrix at a higher density than in the first variation and encapsulated in droplets much smaller than in the first variation. These droplets can be polymerized and resuspended in fresh, non-polymerized extracellular matrix. This suspension can be processed again to form new droplets of approximately the same size as in the first variation, containing a single high-density polymerized cell core.

[0134]

[0153] As shown in Figure 19, the generation of organic microspheres can include one or more forms of cell encapsulation. In Scenario A (1910), a single-cell suspension can be added to the extracellular matrix, and the organic microsphere generator may be configured to produce a set of organic microspheres containing a predetermined number of cells diffused throughout the droplet upon generation. These droplets can then be polymerized and analyzed. Alternatively, in Scenario B (1920, 1930), cells can be encapsulated in multiple steps to create a high-density core of cells within a larger extracellular matrix droplet. In Scenario B, single cells can be resuspended in the extracellular matrix at a higher concentration than in Scenario A and encapsulated in much smaller droplets than in Scenario A. These droplets can then polymerize and be resuspended in fresh, unpolymerized extracellular matrix. This suspension can be processed again with the organic microsphere generator to create new droplets of the same size as in Scenario A, containing a single polymerized high-density cell core. These droplets can then follow the same operational and analytical procedures as in Scenario A.

[0135]

[0154] In some variations, organic microspheres can be immobilized on a surface. For example, organic microspheres can be immobilized at the bottom of a well or culture plate.

[0136]

[0155] If the organic microspheres contain magnetic particles and / or magnetizable particles, magnetic force can be used to immobilize the organic microspheres in place. For example, the magnetic force can be applied to the center of the well. Data acquisition can be efficient when using a high-throughput imager if all organic microspheres can be captured in the field of view and concentrated in the center of the well.

[0137]

[0156] In some variations, organic microspheres can also be immobilized at specific locations through biochemical means, which may involve utilizing the chemical composition of the extracellular matrix gel to capture gel-based organic microspheres using antibodies that specifically bind to the extracellular matrix gel.

[0138]

[0157] In some variations, antibodies can be immobilized at the bottom of the well or culture plate in at least two ways. In some variations, antibodies can bind directly to the surface of an untreated polystyrene culture dish by incubation in a high pH, ​​low ionic strength buffer such as phosphate-buffered saline (PBS). In this environment, antibodies can preferentially bind to the surface through hydrophobic interactions with polystyrene.

[0139]

[0158] In some variations, the culture plate may be pre-coated with protein A or protein G before antibody adhesion. Since proteins A / G bind to the Fc region of the antibody, this technique allows the variable region of the antibody to be directed toward the bulk solution and appropriately oriented away from the plate surface. In some variations, the antibody may be incubated with a high pH and a low ionic strength buffer such as PBS to induce binding to the plate.

[0140]

[0159] In some variations, approximately 1–10 ug of antibody can be immobilized on the plate surface after washing. The majority of several extracellular matrix gels are composed of type IV collagen and laminin. Culture plates incubated with Matrigel®-based organic microspheres, derivatized with anti-mouse laminin antibody and / or anti-mouse type IV collagen antibody, can be immobilized on the culture plate via the antibody. For example, Figures 18A and 18B are graphs showing the derivatization of culture plates with mouse anti-laminin response and / or mouse anti-type IV collagen antigen via either polystyrene (Figure 18A) or protein A medium adhesion (Figure 18B), leading to antibody concentration-dependent immobilization of Cultrex-based organic microspheres, minimizing losses incurred due to medium changes. Data are plotted as the mean with error, represented as SEM of 5 replication measurements of droplets per well in a 96-well plate. In some variations, supernatant exchange can be performed with minimal organic microspheroid loss after incubation at 37°C for at least 16 hours.

[0141]

[0160] In some variations, organic microspheres can be deposited at the bottom of the well or culture plate by centrifugation. Using specific geometries, organic microspheres can be concentrated in a predetermined location.

[0142]

[0161] In some modifications, organic microspheres can be localized to a predetermined location at the bottom of a well or culture plate. For example, a pattern can be created at the bottom of the well or culture plate to facilitate localization. In some modifications, depressions can be etched at the bottom of the well or culture plate to increase affinity for organic microspheres. In some modifications, after coating the bottom of the well or culture plate with a material that has affinity for organic microspheres, a laser etcher can be used to remove the coating from all areas where organic microspheres are not desired. The pattern is not limited to wells or culture plates and can also be applied to other containers.

[0143]

[0162] In some variations, step 912 may generate sensor data corresponding to an organic microspheroid formation process (e.g., cells, fluid matrix material, mixture). For example, the sensor data may be generated by one or more sensors 116 of system 100, which are described in more detail herein.

[0144]

[0163] In some variations, imaging data corresponding to the organic microspheroid formation process (e.g., cells, fluid matrix material, mixture) can be generated according to step 914. For example, the imaging device 132 described herein may be configured to generate imaging data corresponding to mixture formation (e.g., the intersection of cells and fluid matrix material at intersections or junctions). In some variations, the formed organic microspheroids can be imaged for further analysis.

[0145]

[0164] In some variations, according to step 916, one or more properties of the mixture and / or organic microspheres can be estimated based on sensor data and / or imaging data. For example, imaging data may be processed to generate the size distribution of the formed droplets. In some variations, one or more properties may include one or more such as the number of cells per droplet, the distribution of cells within the droplet, and the size of the droplet (e.g., diameter).

[0146]

[0165] In some variations, the properties of organic microspherical bodies can be estimated through the acquisition of imaging data without sensor data.

[0147]

[0166] In some variations, the characteristics of organic microspheres can be estimated based on imaging data. For example, step 1010 in Figure 10 shows that a subset of the formed organic microspheres can be stained with AO / PI to count the number of living and dead cells per organic microsphere. The estimated characteristics can, for example, allow for the rejection of runs with a number of dead cells (or dead cell density) exceeding a predetermined threshold.

[0148]

[0167] The systems and devices described herein can be used to form organic microspheres containing a predetermined number of cells. For example, in a set of 25 runs targeting 20 cells per organic microsphere, organic microspheres were formed with an average of 19.3 viable cells per droplet and viable cell percentages (CV) of 13.3% and 13.1% per droplet, respectively.

[0149]

[0168] Regarding diameter, Figure 11 shows that a subset of the formed organic microspheres (e.g., about 100 droplets) can be imaged using high-throughput microscopy. Image analysis can generate estimates of the average diameter and variability (%CV). Runs outside a predetermined diameter range can be rejected.

[0150]

[0169] The systems and devices described herein can be enabled to form organic microspheres having a predetermined diameter. For example, a set of 42 runs targeting 300 μm cells formed organic microspheres with an average diameter of 302 μm and droplet diameters %CV (intra-run and inter-run) of 20.2% and 11.1%, respectively.

[0151]

[0170] Returning to Method 900, in some variations, one or more organic microspheroid formation parameters may be updated based on estimated properties according to step 918. For example, the sample and fluid temperatures and / or fluid flow rates may be adjusted based on estimated properties. This can increase the efficiency and yield of closed-loop control of the organic microspheroid formation process. In some variations, properties may be estimated using imaging data without sensor data. One or more of the temperature, fluid flow rate, and / or other conditions may be adjusted based on estimated properties.

[0152]

[0171] In some variations, the mixture can be polymerized according to step 920 to form a set of organic microspheres. In some variations, the mixture (e.g., droplets) can be polymerized in an immiscible material (e.g., oil) to form organic microspheres. For example, the immiscible material can be heated to a temperature that polymerizes the non-polymerizable mixture (e.g., a fluid matrix material in the non-polymerizable material).

[0153]

[0172] In some variations, a set of organic microspheres can be demulsified according to step 922. For example, the organic microspheres can be separated from the immiscible fluid by shearing and / or by using the demulsifier 600 described in relation to Figure 6A or the demulsifier 602 described in relation to Figure 6B.

[0154]

[0173] In some variations, a set of organic microspheres may be stirred according to step 924. Figure 12 shows a set of organic microspheres suspended in solution and stirred to distribute them more uniformly.

[0155]

[0174] In some variations, a set of organic microspheres can be output according to step 926. In some variations, droplets can be dispensed using pressure, sound, electric charge, or a combination thereof. For example, as shown in Figure 12, a liquid handler can be used to dispense a predetermined volume of organic microspheres (at a predetermined concentration) into a growth container (e.g., a 96-well plate, a 384-well plate, or a 1536-well plate). For example, controlling the total cell mass dispensed into the wells can facilitate quantitative measurements that rely on cell activity.

[0156]

[0175] In some variations, imaging data for a set of organic microspheres can be generated according to step 928. For example, organic microspheres in each well of a well plate can be imaged and analyzed. In some variations, one or more characteristics of a set of organic microspheres can be estimated based on the imaging data according to step 930. For example, Figure 13 shows that a set of organic microspheres can be imaged using high-throughput microscopy. Image analysis can generate estimates of the average number and variation (%CV) of organic microspheres per well. Runs outside a predetermined range of values ​​can be rejected.

[0157]

[0176] In some variations, droplet diameter can be controlled by the system configuration, the ratio of sample to matrix (e.g., Matrigel®), and the number of cells per droplet. Droplet diameter can be monitored by measuring the average droplet size and dispersion (%CV) after any organic microspheroid formation run and image analysis via high-throughput microscopy. In some variations, the average droplet size and dispersion can be estimated by imaging samples of approximately 100 droplets. Runs that do not meet the average threshold and dispersion threshold can be repeated.

[0158]

[0177] The systems and devices described herein may enable the formation of organic microspheres having a predetermined diameter. For example, a set of 42 runs targeting 300 μm cells formed organic microspheres with an average diameter of 302 μm and droplet diameters %CV (intra-run and inter-run) of 20.2% and 11.1%, respectively.

[0159]

[0178] The systems and devices described herein can be configured to output a predetermined number of organic microspheres per well. For example, a set of runs targeting 30 organic microspheres per well had an average number of organic microspheres per well and a droplet count (CV) of 20.6% (intra-run and inter-run) of 20.6% for both 31.2 wells.

[0160]

[0179] In some variations, a set of organic microspheres can be cultured according to step 932. For example, culture medium can be provided to the organic microspheres to allow them to establish and grow. In some variations, the organic microspheres can be cultured for any desired time, or cryopreserved and / or immediately assayed. In some variations, the organic microspheres can be cultured for about 1 to 3 days, about 1 to 4 days, about 1 to 5 days, about 1 to 6 days, about 1 to 7 days, about 1 to 8 days, about 1 to 9 days, about 1 to 10 days, about 1 to 11 days, and about 1 to 14 days, including all values ​​and partial ranges between them. In some variations, the cells within the organic microspheres can grow and / or divide (e.g., 2x) up to about 6 passages. After culture, the cells can be cryopreserved and / or assayed, for example.

[0161]

[0180] In some variations, the culture medium for organic microspheroids may include a basic medium (e.g., DMEMF12 or RPMI1640), a buffer (e.g., HEPES), glutamic acid, antibiotics, or combinations thereof. The culture medium may be further supplemented with growth factors appropriate to the cell type being cultured. Table 1 provides exemplary growth factors that may be used to supplement the growth medium to produce organoids of the indicated cell types.

[0162] [Table 1]

[0163]

[0181] In an exemplary method, a tissue sample from a clinical biopsy may be subdivided or re-excised, then suspended in a temperature-sensitive gel (Matrigel®) at approximately 4°C, and subsequently flowed through a microfluidic droplet tip. In some variations, the number of cells in the homogenized tissue sample may be estimated using an automated cell counter, and then resuspended in the gel at a specific desired density to provide a predetermined number of cells per droplet based on a given droplet volume. In some variations, the core T-shaped junction of the microfluidic device may be configured to produce gel-like water-in-oil droplets with substantially uniform volume and material composition. The homogenized tissue sample in the gel may be divided into droplets, "microreactors," and the gel may solidify upon incubation at approximately 37°C. By deemulsification, organic microspherical bodies containing droplets can be recovered from the oil phase. The resulting product may contain, for example, thousands of homogeneous gel tumor droplets compatible with conventional 3D cell culture techniques.

[0164]

[0182] In further exemplary methods, patient / donor-derived organic microspheroids may be regularly monitored using imaging-based techniques to acquire 3D structures (e.g., multiple cells and intercellular contacts) that can more accurately mimic the biology of the parental tumor than 2D culture formats. In some variations, the determination of “establishment” is based on the systematic acquisition of 3D structures across large, representative samples of droplets, based on imaging data described herein. The imaging data may include microscopic images taken once daily and analyzed to estimate the diameter of objects within the droplets, which can be used to generate plots of object size distribution. If droplet objects systematically and consistently grow beyond a diameter representing a single cell, the sample can be considered “established” and therefore considered to biologically represent the parental tumor.

[0165]

[0183] In some deformations, the size is approximately 700 μm. 2 Organoids within organic microspherical bodies with a larger measured surface area than the above can be considered established. The maximum surface area of ​​organoids occupying the entire droplet is approximately 96,000 μm². 2Therefore, since each assay well may have two or more droplets, at least one droplet in a well must meet a set of predetermined criteria (e.g., approximately 700 μm). 2 If the surface area exceeds a certain value, it is considered established and can be used for downstream assays. In some variations, assay wells are such that approximately 30% of the droplets measured in the wells are approximately 700 μm. 2 It can be considered established if it has at least one organoid having a surface area of ​​.

[0166]

[0184] As shown in the images (1500, 1510) of Figures 15A and 15B, when cultured, organoids within organic microspheres grow rapidly and establish themselves as organoids. During the initial growth stage, a single droplet may contain multiple organoids. Over time, multiple organoids fuse to form larger organoids, potentially forming one organoid per droplet. Images (1600, 1610) of Figure 16 allow for a comparison of microorganoids with conventional organoids. For example, a fresh clinical breast cancer sample was digested and split in half for organic microsphere generation and organoid generation. Organic microspheres were seeded in 96-well plates with 60 cells / droplet, and the same number of cells / well were seeded in Matrigel® domes for organoid culture in a separate 96-well plate. After approximately three days, the organic microspheroids had already formed large 3D structures (approximately 200 μm in diameter) and were ready for use in drug assays. However, the 3D structures in conventional organoid cultures were small and sparsely distributed. Representative 4X images of wells from each culture are shown in Figure 16 (1600, 1610).

[0167]

[0185] The organic microspheres described herein can be used as a healthy tissue model or a diseased tissue model. Accordingly, this disclosure relates to a method for identifying a patient's response to a treatment, the method comprising (a) obtaining a biological sample having cells from a patient, (b) encapsulating the cells in organic microspheres, (c) contacting the organic microspheres with a treatment, (d) performing an assay on the organic microspheres, and (e) identifying the response to the treatment based on the results from the assay. In some variations, the treatment includes a drug or drug candidate. In some variations, the treatment includes chemotherapy, targeted therapy, or immune cell-based therapy. In particular, this disclosure allows for rapid assessment of a patient's response to a treatment, for example, within about 14 days of receiving cells from the patient. In some variations, the assessment may include identifying the response of healthy tissue to a given treatment (e.g., a drug or drug candidate). In some variations, the response may include toxicity and / or another measurable drug response.

[0168]

[0186] In some variations, the assay is a cell viability assay. Examples of cell viability assays include, but are not limited to, cellTiter-Glo® and cellTiter-Glo® 3D live / dead fluorescence labeling and imaging.

[0169]

[0187] In some variations, the assay is a cell painting assay, e.g., in-situ fluorescent staining of cells within organic microspheroids. In a cell painting assay, one or more fluorophores are tagged to one or more protein / cellular structures or extracellular structures. See, for example, Bray et al., “Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes,” Nature Protocols 2016, 11, 1757–1774. This information is incorporated herein by reference.

[0170]

[0188] Additional data can also be obtained from biological samples and / or organic microspheres by performing various characterization methods known in the art, such as histology (e.g., E&H and IHC staining of FFPE blocks of DMOS), DNA / RNA assays, bulk cell viability assays (e.g., cellTiter-Glo® / cellTiter-Glo® 3D), proteomics, and ctDNA assays from the supernatant. Characterization methods can be performed on each organic microsphere as a whole or on parts thereof, such as cells or microstructures within the organic microspheres. Cells can be extracted from the organic microspheres through, for example, single-cell sequencing, flow cytometry, FACS, or other techniques and analyzed or manipulated independently. Characterization methods can also be performed on the supernatant obtained from a solution or suspension containing organic microspheres.

[0171]

[0189] In some variations, the biological sample is tumor tissue. Therefore, in addition to organic microspheres, measurements performed on the tumor tissue itself can provide additional data that helps identify the patient's response to treatment.

[0172]

[0190] Where used herein, sterilization should be understood as a non-exclusive description of several variations, optional features, that provide advantages in the operation of the particular systems and methods of this disclosure. Maintaining sterility is typically desirable, but not limited to, the provision of sterile reagents, culture media, cells, and other solutions; sterilization of cartridges and / or cartridge components after loading (protecting cellular products from destruction); and / or the operation of systems within sterile enclosures, environments, buildings, rooms, etc. Such sterilization steps performed by a user or system can sterilize the cartridge or cartridge components and / or maintain the sterility of the cartridge or cartridge components.

[0173]

[0191] All cited references are incorporated herein by reference.

[0174]

[0192] As used herein, the singular forms "a," "an," and "the" include the plural form unless the context clearly indicates otherwise. As used herein, "and" is used synonymously with "or" unless otherwise specified.

[0175]

[0193] As used herein, the terms “substantially,” “approximately,” and “about” generally mean plus or minus 10% of the stated value, for example, about 100 includes 90 to 110.

[0176]

[0194] Where used herein, the “and / or” clause should be understood to mean “either or both” of the elements thus connected, i.e., elements that may be present either connectively or disconnectively. Multiple elements listed using “and / or” should be interpreted similarly, i.e., “one or more” of the elements thus connected. Other elements may exist, at their discretion, whether related to or unrelated to the elements specifically identified by the “and / or” clause. Thus, as a non-restrictive example, a reference to “A and / or B,” when used in conjunction with open-ended language such as “includes,” may refer to A only (optionally including elements other than B) in one variation, B only (optionally including elements other than A) in another variation, and both A and B (optionally including other elements) in yet another variation, and so on.

[0177]

[0195] Where used herein, “or” should be understood to have the same meaning as “and / or” as defined above. For example, when separating items in a list, “or” or “and / or” should be interpreted as inclusive, that is, including some of the elements or at least one of the list, but including two or more and optionally additional unlisted items. Only terms that explicitly indicate the opposite, such as “one of” or “strictly one of,” or, when used in claims, “consisting of,” refer to the inclusion of some of the elements or strictly one of the list. In general, where used herein, the term “or” should be interpreted as indicating only exclusive substitutions (i.e., “one or the other, but not both”) when preceded by terms of exclusivity such as “either one,” “one of,” “one of,” or “strictly one of.” Where used in claims, “basically consists of” should have the usual meaning as used in the field of patent law.

[0178]

[0196] As used herein, the phrase “at least one” in relation to a list of one or more elements means at least one element selected from any one or more elements in the list of elements, but should be understood not to necessarily include at least one of every element specifically listed in the list of elements, nor to exclude any combination of elements in the list of elements. In this definition, elements other than those specifically identified in the list of elements referred to by the phrase “at least one” may also be present, whether related to or unrelated to those specifically identified elements. Therefore, as a non-limiting example, "at least one of A and B" (or equivalently "at least one of A or B" or equivalently "at least one of A and / or B") may mean, in one variation, that it includes at least one optionally two or more A's and no B (optionally including elements other than B); in another embodiment, that it includes at least one optionally two or more B's and no A (optionally including elements other than A); and in yet another embodiment, that it includes at least one optionally two or more A's and at least one optionally two or more B's (optionally including other elements).

[0179]

[0197] All variations of any aspect of this disclosure can be used in combination unless the context clearly indicates otherwise.

[0180]

[0198] Unless otherwise clearly required by the context, throughout this description and the claims, words such as “comprise,” “comprising,” and so on should be interpreted in an inclusive sense, as opposed to an exclusive or exhaustive sense, i.e., “not limited to, but including.” Words used in the singular or plural also include the plural and singular, respectively. Furthermore, when used in this application, words such as “in this specification,” “above,” “below,” and words with similar meanings should refer to the application as a whole, and not to any specific part thereof.

[0181]

[0199] While variations of the present invention have been shown and described herein, those skilled in the art will understand that such variations are provided merely as examples. Those skilled in the art will now be able to conceive of many variations, modifications, and substitutions without departing from the present invention. It should be understood that various substitutes for the variations of the present invention described herein are possible when carrying out the present invention. The following claims define the scope of the present invention, and the methods and structures within these claims and their equivalents are intended to be encompassed thereby.

Claims

1. a droplet generator including a microfluidic device and configured to form a set of droplets from the mixture of the biological sample and the fluid; a controller coupled to the imaging device; Including, The controller: receiving imaging data corresponding to one or more of the mixture or the set of droplets; Estimating one or more properties of the set of droplets based on at least the imaging data; and A system configured to:

2. The system of claim 1 , further comprising an imaging device configured to generate the imaging data corresponding to the one or more of the mixture or the set of droplets.

3. a cell culture vessel coupled to the imaging device and configured to culture the set of droplets in a plurality of wells; The controller: The system of claim 2 , further configured to estimate a number of droplets in the plurality of wells based on at least the imaging data.

4. further comprising one or more sensors coupled to the microfluidic device and configured to generate sensor data corresponding to the mixture or the set of droplets; The controller: receiving the sensor data from the one or more sensors; estimating one or more characteristics of the set of droplets based at least on the sensor data; and The system according to any one of claims 1 to 3, further configured to:

5. one or more pumps coupled to the microfluidic device and configured to control fluid flow to the microfluidic device; a temperature regulator coupled to the microfluidic device, a sample source, or a fluid source and configured to control a temperature of the sample source, the fluid source, the mixture, or the set of droplets; Further comprising: The controller: The system of claim 4 , configured to modify one or more of the pump or the temperature based on at least the imaging data and the sensor data.

6. a polymerization chamber fluidly coupled to the microfluidic device and configured to polymerize the mixture to form the set of droplets; a demulsifier fluidly coupled to the microfluidic device and configured to demulsify the mixture to form the set of droplets; an agitator configured to agitate the droplets within a fluid of a predetermined concentration; The system according to any one of claims 1 to 3, further comprising:

7. the one or more of the characteristics of the set of droplets include one or more of a droplet diameter, a total number of cells, or a number of live cells; the controller is configured to estimate one or more properties of the mixture based on at least the imaging data; and / or the imaging data corresponds to the biological specimen, and the controller is configured to estimate one or more properties of the biological specimen based on at least the imaging data. A system according to any one of claims 1 to 3.

8. The one or more of the properties of the mixture include total cell number and viable cell number; and / or the one or more characteristics of the biological sample include total cell number and viable cell number; The system of claim 7.

9. The system of claim 6 , wherein the demulsifier comprises a flow separator configured to separate the set of droplets.

10. The system of claim 9 , wherein the flow separator extends along a length of the demulsifier.

11. the set of droplets having a diameter of about 200 μm to about 400 μm; the droplet generator is configured to form the set of droplets from the biological sample comprising a volume of up to about 1 mL; and / or the droplet generator is configured to form the set of droplets from the biological sample comprising less than about 10,000 cells. A system according to any one of claims 1 to 3.

12. The system of claim 11, wherein the biological sample comprises about 3,500 to about 7,500 cells.

13. the droplet generator is configured to form the set of droplets from the biological sample having a volume of about 5 μL to about 5 mL; and / or the set of droplets comprising a set of non-cellular objects; A system according to any one of claims 1 to 3.

14. the biological sample has a volume of about 5 μL, about 10 μL, about 20 μL, about 35.3 μL, about 50 μL, about 100 μL, about 250 μL, about 500 μL, about 1 mL, about 1.5 mL, about 2 mL, about 2.5 mL, about 3 mL, about 3.5 mL, about 4 mL, about 4.5 mL, or about 5 mL; and / or the set of non-cellular objects includes one or more inert particles; The system of claim 13.

15. The system of claim 14, wherein the set of non-cellular objects comprises from about 1 to about 5,000 inert particles.

16. a droplet generator configured to form a set of droplets from the mixture of the biological sample and the fluid; A controller; Including, The controller: receiving imaging data corresponding to the set of droplets; identifying the set of droplets having a diameter between about 50 and about 500 μm based on at least the imaging data; A system configured to:

17. The system of claim 16 , further comprising an imaging device configured to generate the imaging data corresponding to the set of droplets.

18. The system of any one of claims 1 to 3 and 16 to 17, wherein the biological sample corresponds to a biopsy of a patient.

19. A method of producing a droplet composition in a system according to any one of claims 1 to 18, comprising the steps of: providing said biological sample comprising dissociated cells and a non-polymeric substrate; forming the mixture from the biological sample in an immiscible solution; polymerizing the mixture to form a set of droplets; The method includes:

20. The method of claim 19, comprising: and further comprising dissociating the biological sample to obtain the dissociated cells. the substrate is temperature sensitive and polymerization occurs when the temperature of the mixture is increased; the set of droplets having an average diameter of about 50 μm to about 500 μm, a coefficient of variation (CV) of less than about 30%, less than about 20%, or less than about 10%; The method comprises: further comprising performing an assay on the droplets to identify a treatment response; the droplets comprise about 1 to about 1,000 dissociated primary cells dispersed within the substrate; and / or The biological sample corresponds to a biopsy of a patient. method.

21. sorting the droplets by size to form the set of droplets having an average diameter of about 50 μm to about 500 μm and a coefficient of variance (CV) of less than about 30%, less than about 20%, or less than about 10%; or controlling one or more flow rates in the droplet generator to form the set of droplets having an average diameter of about 50 μm to about 500 μm and a coefficient of variation (CV) of less than about 30%, less than about 20%, or less than about 10%; 21. The method of claim 19 or 20, further comprising:

22. the assay is a cell viability assay or a cell staining assay; and / or The assay is performed within 14 days or less from when the biological sample is obtained from the patient.

21. The method of claim 20.

23. A droplet composition comprising a plurality of droplets, each droplet comprising a substrate and at least one organoid; The plurality of droplets have parameters including a predetermined number of cells per droplet, a predetermined number of droplets per composition, and / or a predetermined droplet size, each of the parameters independently having a coefficient of variance (CV) of less than about 30%, less than about 20%, or less than about 10%.

24. the average diameter of each droplet in the composition is from about 50 μm to about 500 μm; Each droplet contains a substrate and only one organoid, Each droplet further comprises inert particles; the plurality of droplets includes tissue from a biopsy of a patient; and / or The droplet comprises about 1 to about 1,000 dissociated primary cells dispersed within the substrate.

24. The composition of claim 23.

25. the average diameter of each droplet in the composition has a coefficient of variation (CV) of less than about 30%, less than about 20%, or less than about 10%; the inert particles are magnetic particles, magnetizable particles, fluorescent particles, or a combination thereof; Each droplet contains from about 1 to about 5,000 inert particles; and / or The tissue comprises non-cultured cells.

25. The composition of claim 24.

26. 1. A method for immobilizing droplets in a well or culture plate, comprising: Providing a plurality of droplets, each droplet comprising a substrate, at least one organoid, and magnetic or magnetizable particles; applying a magnetic field to the well or culture plate, thereby immobilizing the droplet on a surface of the well or culture plate; The method includes:

27. The well or the culture plate has a bottom, 27. The method of claim 26, wherein the droplet is immobilized on the bottom of the well or culture plate.

28. 1. A method for immobilizing a droplet in a well or culture plate having a bottom, comprising: providing a plurality of droplets, each droplet comprising a substrate and at least one organoid; functionalizing the bottom with an antibody that binds to the substrate; contacting the droplet with the antibody, thereby immobilizing the droplet on the bottom; The method includes:

29. The antibody is immobilized on the bottom by incubation, and / or The bottom is coated with protein A and / or protein G prior to the functionalization.

30. The method of claim 28.

30. 1. A method for determining a patient's response to a treatment, comprising: performing an assay on the droplet, the droplet comprising: mixing a biological sample containing dissociated cells from said patient with a non-polymeric substrate in an immiscible solution to form a mixture; by polymerizing said mixture to form a set of droplets.

31. the assay is a cell viability assay or a cell staining assay; and / or The assay is performed within about 14 days or less from when the biological sample is obtained from the patient.

31. The method of claim 30.

32. 32. The method of any one of claims 26 to 31, wherein the droplet comprises about 1 to about 1,000 dissociated primary cells dispersed within the substrate.